Molecular Genetics of X-Chromosomal Juvenile Retinoschisis by Huopaniemi, Laura
Department of Medical Genetics
Haartman Institute
University of Helsinki
and
Department of Molecular Genetics
The Folkhälsan Institute of Genetics
and
Department of Obstetrics and Gynecology
Helsinki University Central Hospital
MOLECULAR GENETICS OF
   X-CHROMOSOMAL JUVENILE RETINOSCHISIS
LAURA HUOPANIEMI
Academic dissertation
To be publicly discussed with the permission of the Faculty of Medicine,  for the
 Department of Medical Genetics, University of Helsinki, in the lecture hall of the
Department of Ophthalmology, University of Helsinki, Haartmaninkatu 4, Helsinki,
 on May 25th , 2000, at 12 o’clock  noon.
Helsinki 2000
2Supervised by
Docent Tiina Alitalo, PhD
Department of Medical Genetics,
Haartman Institute/
The Folkhälsan Institute of Genetics
University of Helsinki
and
Department of Obstetrics and Gynecology
Helsinki University Central Hospital
Reviewed by
Professor Marja-Liisa Savontaus
Department of Medical Genetics
University of Turku
Turku, Finland
Professor Ann-Christine Syvänen
Department of Medical Sciences
Uppsala University Hospital
Uppsala, Sweden
Official opponent
Docent Jaakko Ignatius, MD, PhD
Department of Clinical Neurophysiology,
Jorvi Hospital, Espoo, Finland
ISBN 952-91-2068-0 (pdf version, http:// ethesis.helsinki.fi)
Gummerus kirjapaino
Saarijärvi  2000
3Every house has many builders
and is never finished.
P. HAAVIKKO
To My Family
4TABLE OF CONTENTS
LIST OF ORIGINAL PUBLICATIONS........................................................................................ 7
ABBREVIATIONS ................................................................................................................... 8
SUMMARY...........................................................................................................................10
1. THE FINNISH DISEASE HERITAGE.............................................................................. 12
2. INHERITED RETINAL DISEASES.................................................................................. 14
2.1 The vertebrate retina: Development, structure, and function.............................................14
2.2 Steps of the visual cascade...........................................................................................15
2.3 Genetic diseases affecting the retina.............................................................................16
2.4 Genes causing hereditary retinal diseases......................................................................16
3. X-CHROMOSOMAL JUVENILE RETINOSCHISIS........................................................... 19
3.1 Main clinical findings.................................................................................................19
3.2 Geography of RS ........................................................................................................20
3.3 Previous mapping studies in X-chromosomal retinoschisis .................................................20
3.4 Identification of the retinoschisis gene...........................................................................21
3.5 Discoidin domain proteins ...........................................................................................22
3.6 Other types of retinoschisis..........................................................................................24
4. HUMAN X : AN EXCEPTIONAL CHROMOSOME .......................................................... 25
4.1 Sex determination and X-Y homology..............................................................................25
4.2 Dosage compensation: 2X=1X ......................................................................................26
4.3 Non-random X-inactivation..........................................................................................27
4.4 Genes escaping X-inactivation .....................................................................................27
        5. DISEASE GENE IDENTIFICATION....................................................................................29
5.1 Cloning approaches....................................................................................................29
5.2 Polymorphisms as genetic markers................................................................................30
5.3 Principles of  linkage analysis ......................................................................................31
5.4 Linkage disequilibrium mapping....................................................................................32
5.5 Physical mapping .......................................................................................................33
5.6 Identification of expressed  gene  sequences....................................................................34
5.7 Sequence databases and  in silico cloning.......................................................................34
5.8 Mutation identification : Unknown mutations..................................................................35
5.9 Screening of known mutations.......................................................................................36
AIMS OF THE PRESENT STUDY............................................................................................38
MATERIALS AND METHODS ................................................................................................39
1. RS families and control individuals .................................................................................39
2. DNA and RNA extraction ..............................................................................................39
3. Isolation of novel microsatellite markers .........................................................................39
4. Genotyping.................................................................................................................39
5. Linkage analysis ..........................................................................................................40
6. Linkage disequilibrium and haplotype analysis .................................................................40
7. Physical mapping.........................................................................................................40
7.1 Yeast artificial clone contig and restriction mapping ........................................................40
7.2 Cosmid contig............................................................................................................41
8. Large scale sequencing and sequence analysis..................................................................41
59. Mutation analysis ........................................................................................................41
9.1 SSCP analysis............................................................................................................41
9.2 Restriction enzyme based mutation detection..................................................................42
9.3 RFLP analysis ...........................................................................................................42
9.4 Genomic walking .......................................................................................................42
10. Secondary sex ratio (SSR) studies..................................................................................42
11. RS1 gene expression analysis:  cDNA synthesis and RT-PCR..............................................43
12. X-inactivation analysis................................................................................................43
1. REFINED LOCALIZATION OF THE RS GENE (I, III) ...................................................... 44
1.1Genetic mapping.........................................................................................................44
1.1.1 Linkage studies and recombination mapping (I) .............................................................44
1.1.2 Haplotype analysis with the basic marker set favours the hypothesis of
           two founder mutations (I)...........................................................................................44
1.1.3 Linkage disequilibrium studies suggest  the critical region of  300 kb (I).............................45
1.2 Physical mapping of the RS critical  region......................................................................46
1.2.1 YAC contig based restriction mapping (I) .....................................................................46
1.2.2 Construction of a cosmid/PAC contig (unpublished) ......................................................46
1.3 Large scale sequencing and identification of candidate genes (unpublished).........................48
1.4 The extended haplotype analysis and genealogical studies reveal a third
        founder haplotype (III, unpublished)..............................................................................48
1.5 Identification of the retinoschisis gene...........................................................................50
2. MUTATION ANALYSES OF THE RS1 GENE (II,III,IV).................................................. 51
2.1 Finnish mutations (III) .................................................................................................51
2.2 Mutations in foreign RS patients (II) ..............................................................................52
2.3 Deletion mutations in Danish patients (IV) ......................................................................53
2.4 Distribution of identified mutations ...............................................................................54
2.4.1 Single nucleotide substitutions: uneven distribution over the RS1 gene (II,III, unpublished) ..54
2.4.2 Large intragenic deletions are predominantly found in the 5’ part  of the gene (II, IV)...........55
2.5 Phenotype-genotype correlation (II,III,IV) ......................................................................56
3. SECONDARY SEX RATIO AND GENE EXPRESSION STUDIES (V)................................. 57
3.1 Secondary sex ratio (V) ...............................................................................................57
3.2 RS1 expression in the pregnancy related tissues (V)..........................................................58
3.3 X-inactivation analysis of RS carriers (V) .......................................................................59
CONCLUSIONS AND FUTURE PROSPECTS...........................................................................60
ACKNOWLEDGEMENTS........................................................................................................62
REFERENCES.......................................................................................................................64
7LIST OF ORIGINAL PUBLICATIONS
This thesis is based on the following original publications, which are referred to in
the text by their Roman numerals.
I Huopaniemi Laura, Rantala Anne, Tahvanainen Esa, de la Chapelle Albert, Alitalo
Tiina: Linkage disequilibrium and physical mapping of X-linked juvenile
retinoschisis. (1997) American Journal of Human Genetics 60:5, 1139-1149
II The Retinoschisis Consortium*: Functional implications of the spectrum of
mutations found in 234 cases with X-linked retinoschisis XLRS1. (1998) Human
Molecular Genetics 7:7, 1185-1192. (*Group 4: Huopaniemi Laura, Rantala Anne,
Rosenberg Thomas, Dahl Niklas, Wright Alan, de la Chapelle Albert, Alitalo Tiina)
III Huopaniemi Laura, Rantala Anne, Forsius Henrik, Somer Mirja, de la Chapelle
Albert, Alitalo Tiina: Three widespread founder mutations contribute to high
incidence of X-linked juvenile retinoschisis in Finland. (1999) European Journal of
Human Genetics 7:3, 368-376.
IV Huopaniemi Laura, Tyynismaa Henna, Rantala Anne, Rosenberg Thomas, Alitalo
Tiina: Characterization of two unusual RS1 gene deletions segregating in Danish
retinoschisis families. Submitted.
V Huopaniemi Laura, Fellman Johan, Rantala Anne, Eriksson Aldur, Forsius Henrik, de
la Chapelle Albert, Alitalo Tiina: Skewed secondary sex ratio in the offspring of
carriers of the 214G>A mutation of the RS1 gene. (1999) Annals of Human
Genetics, 63:6, 521-533.
In addition, some unpublished data are presented.
8ABBREVIATIONS
ABCR retina specific ATP-binding cassette transporter gene
ad autosomal dominant
AGA aspartylglucosaminidase gene
AIPL1 arylhydrocarbon interacting protein-like-1 gene
AIRE autoimmune regulator
ar autosomal recessive
AP 1/2 adaptor primer 1/2
APECED autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
BAC bacterial artificial chromosome
B.C. before Christ
bp base pair
cDNA complementary DNA
cGMP cyclic guanosine monophosphate
cM centiMorgan
CHM choroideremia
CLN5 Finnish variant of late infantile neuronal ceroid lipofuscinosis gene
CORD2 ad cone–rod dystrophy
CRD cone-rod dystrophy
CRX photoreceptor specific homeodomain transcription factor gene
CUBN intrinsic factor-vitamin B12 receptor gene
DGGE denaturing gradient gel electrophoresis
DS discoidin domain
DTD diastrophic dysplasia
ERG electroretinogram
EST expressed sequence tag
FAF familial amyloidosis of Finnish type
FISH fluorescence in situ hybridization
FSHR follicle-stimulating hormone receptor gene
GSP 1/2 gene specific primer 1/2
GDP guanosine diphosphate
GTP guanosine triphosphate
ICRF Imperial Cancer Research Fund
IL9R interleukin–9 receptor gene
kb kilo base pair
kD kiloDalton
LD linkage disequilibrium
Mb mega base pair
nd not determined
NPHS1 congenital nephrotic syndrome gene
OAT hyperornithemia with gyrate atrophy of the choroid and retina gene
p short arm of a chromosome
PAC P1-derived artificial chromosome
PAGE polyacrylamide gel electrophoresis
PAR pseudoautosomal region
PAX6 paired-box transcription factor regulating eye development
PDE phosphodiesterase
PFGE pulsed field gel electrophoresis
PIC polymorphism information content
PNR photoreceptor specific nuclear receptor
PPEF1 serine-threonine phosphatase gene
PPT palmitoyl protein thioesterase gene
PROM1 prominin (mouse) like-1 gene
q long arm of a chromosome
R rhodopsin
RAI2 retinoid acid induced–2 gene
RDS retina degeneration slow gene
retGC retinal guanylate cyclase gene
RFLP restriction fragment length polymorphism
RHO rhodopsin gene
9ROM1 rod outer segment membrane protein 1 gene
RP retinitis pigmentosa
RPE retina pigmented epithelium
RPE65 a 65 kD retina pigmented epithelium specific protein
RS X-chromosomal retinoschisis
RS1 human X-chromosomal retinoschisis gene
Rs1h mouse X-chromosomal retinoschisis gene
RT-PCR reverse transcriptase polymerase chain reaction
SB1.8 putative chromosomal segregation protein
SCML1 sex-comb on midleg-1 gene
SNP single nucleotide polymorphism
SSCP single strand conformation polymorphism
SSR secondary sex ratio
STK9 serine-threonine kinase gene
STS sequence tagged site
SYBL1 synaptobrevin-like gene 1
T transducin
TMD tibial muscular dystrophy
UBE1 ubiquitin-activating enzyme E1gene
UTR untranslated region
VNTR variable number of tandem repeats
Xi inactive X
XIC X-inactivation center
XIST  X-inactive-specific-transcript
YAC yeast artificial chromosome
Å Ångström
θ theta, recombination fraction
In addition, standard one-letter abbreviations for nucleotides and three-letter abbreviations for amino
acids are used. Symbols for pseudoautosomal genes and genes escaping X-inactivation are presented
in Figure 5 and Table 3.
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SUMMARY
X-chromosomal juvenile retinoschisis (RS) is the leading cause of macular degeneration in
young males. Affected males show vitreoretinal degeneration and splitting of the retinal layers.
Retinoschisis causes progressive, uncorrectable loss of visual acuity, and develops typically early in
life. The RS gene has complete penetrance, but the phenotypic expression of the disease is highly
variable. Female carriers, heterozygous for the gene defect, are asymptomatic.
In this thesis we have concentrated on the molecular genetics of X-chromosomal juvenile
retinoschisis. First, the critical RS region in Xp22 was narrowed by means of genetic and physical
mapping (I). We mapped the RS gene to a 900 kb region, between the markers DXS418 and
DXS7161, by linkage studies. A YAC contig was assembled across the region, including a restriction
map showing the CpG islands. As a collaboration effort of the RS consortium, a PAC contig was
also assembled across the RS candidate region, followed by a large scale sequencing project, which
was initiated at the Sanger center. A total of 1.3 Mb of novel sequence was produced. Several
computer predicted exons were analyzed by SSCP and direct sequencing, but all nucleotide changes
identified were shown to be polymorphisms.
The gene defective in X-chromosomal retinoschisis, RS1, was identified by a German
research group in 1997 by classical positional cloning approach (Sauer et al. 1997). The novel
sequence of the RS candidate region, which was produced at the Sanger center, was vital for the
isolation of this gene. After identification of the gene, we initiated mutation detection studies both in
Finnish and foreign RS patients (II, III, IV). We could demonstrate that three founder mutations
(Western I, Western II, and Northern) contributed primarily to the high incidence of RS in Finland.
In addition, four family specific mutations were identified in the Finnish patients (III). As a result of
mutation analysis of a large set of non-Finnish patients, we detected 82 different RS1 gene defects
including missense mutations, protein truncating mutations and intragenic deletions (II). Finally, two
unique promoter deletions, both leading to either minute amounts or total absence of the RS1 protein,
were identified in Danish RS patients (IV).
It has been noticed earlier that the RS carrier females tend to have more sons than daughters
in their offspring. In order to confirm or contradict these results, we calculated the SSR in the
offspring of 149 Western I mutation carriers and demonstrated that the obtained SSR differed
significantly from that of the Finnish population (V).
The results obtained in these studies enabled us to develop fast and reliable diagnostic
mutation screening methods for retinoschisis families. The significance of a definite carrier
diagnosis is pronounced in the case of retinoschisis, because RS carriership cannot be detected by
clinical methods. The results of our studies have also been a prerequisite for understanding the
11
pathogenesis behind this quite common form of retinal degeneration, and they have provided the
starting point for functional studies of wild type and mutant retinoschisin proteins
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REVIEW OF THE LITERATURE
1. The Finnish Disease Heritage
The Finnish disease heritage is a well-known concept introduced already in the 1970s by Drs
Nevanlinna, Norio, and Perheentupa (Norio et al. 1973; Norio 1981). The term refers to a collection
of inherited disorders that are more prevalent in Finland than in other populations (reviewed in de la
Chapelle 1993; de la Chapelle and Wright 1998; Peltonen et al. 1999). These diseases
characteristically have an autosomal recessive mode of inheritance. In addition, two autosomal
dominant (FAF and TMD) and two X-linked recessive diseases (RS and CHM), are included. On
the other hand, some hereditary diseases, such as cystic fibrosis and phenylketonuria, are common
elsewhere in the world but very rare or even absent in Finland (Visakorpi et al. 1971; Kere et al.
1989). Today, 35 diseases belong to the Finnish disease heritage; the causative genes have been
isolated for 20 of these diseases (Aminoff et al. 1999; Peltonen et al. 1999; Paloneva et al. 2000;
Pellegata et al. 2000). Similar disease gene enrichments are also found in other isolated populations.
For example, among the Old-Order Amish isolates originating from the Berne Canton in
Switzerland, a number of rare hereditary diseases occur with high frequencies (McKusick et al.
1978).
The Finnish disease heritage has its roots and origin in the population history of the country
(Norio 1984). The very first inhabitants came to Finland soon after the last glacial period around
7500 BC (Edgren 1992). The number of inhabitants remained to be very low, until ~ 2000 to 2500
years ago a small number of “founders” from the south, over the Gulf of Finland, immigrated to the
coastal areas of the country. It is hard to estimate the number of these original settlers, but it is
believed to be around hundreds, maybe thousands (Nevanlinna 1972; Norio 1981). For a long time
only the coastal regions of Finland were populated. Internal migration was minimal until the 17th
century. At this time, permanent settlement started to spread towards eastern and northern parts of
the country. Due to large impassable forests and thousands of lakes, the population started to grow
in small isolates (subpopulations) separated from each other. Population bottlenecks, such as wars,
famine, and diseases periodically caused remarkable reductions in the population size. Being
surrounded by the Baltic Sea in the west and south and by the Arctic Ocean in the north, Finland
continued to be isolated from its neighbouring countries. Moreover, linguistic, religious and
geopolitical reasons had an impact on the isolation. As a result, immigration and the flow of new
genes to the Finnish population remained low. These population history characteristics also resulted
in a relatively common occurrence of remotely consanguineous marriages (Norio et al. 1973). The
major population expansion took place after the beginning of the 1700s: during the following ~ 300
year time period the number of inhabitants has reached the figure of over 5 million. Traces of the
unique population history of Finland can be seen still today in the distribution of the Finnish disease
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gene mutations. Older mutations often show quite even distribution throughout the whole country,
whereas younger mutations seem to cluster to more restricted regions (de la Chapelle 1993; de la
Chapelle and Wright 1998).
The peculiar gene frequencies of the Finnish population – enrichment of some genes and
loss of others – mainly result form founder effect and genetic drift. Founder effect refers to
considerable enrichment of a rare allele carried by one of the early settlers in the founding
population, and genetic drift means the effect of randomness in gene frequencies in a given
(sub)population.
The genetic homogeneity of the Finnish population offers an ideal playground for disease
gene identification studies, specifically for Mendelian disorders, but also for more common complex
diseases such as asthma and hypertonia. The number of genes involved in a complex trait is
potentially lower in an isolated population than in a population with mixed genetic background
(Lander and Schork 1994). Other factors favouring genetic research in Finland include the high
quality health care system and the existence of good clinical and epidemiological registers, as well as
accurate church parish registers, which allow the tracing of ancestors of families back to the 16th
century (Varilo et al. 1996). Finally, also the general attitude towards genetic research among the
Finns is favourable (Hietala et al. 1995).
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2. Inherited retinal diseases
2.1 The vertebrate retina: Development, structure, and function  
The vertebrate retina, a multicellular component of the eye, is a specialized part of the central
nervous system. The retina, which is often referred to as “the approachable part of the brain”, has
been extensively studied due to its crucial role in vision, but also as an ideal model for brain
development, function, and pathology. Retinas can be relatively easily removed from the back of an
eye, and they can be kept viable for some hours in suitable in vitro environment. The vertebrate retina
also has good accessibility during embryonic development (Dowling 1987).
Vertebrate eye development involves a series of interactions between the surface ectoderm  and
embryonic forebrain (Saha et al. 1992). The retina is derived from the neural tube: evagination of the
embryonic forebrain forms the optic pit, and deepening of the optic pit results in the formation of the
optic vesicle. Each optic vesicle subsequently invaginates to form the optic cup, which in turn gives
raise to the double layered retina consisting of the neural retina (inner layer) and the retina pigmented
epithelium (outer layer) (Figure 1, Dowling 1987; Saha et al. 1992; Graw 1996). The retina
pigmented epithelium (RPE) is a thin layer lining the back of the eyecup separating the neural retina
from the choroidal vessels. The function of RPE is to transport water and metabolites, phagocytize
photoreceptor outer segments, and maintain a suitable environment for the photoreceptors (Moyer
1969). The cells forming the neural retina continue to proliferate and generate glial cells, ganglion
neurons, interneurons, and light sensitive photoreceptor neurons (Masland 1996). In humans and
rodents, retinal differentiation is not completed at birth but continues postnatally (Graw 1996). The
vertebrate neural retina constitutes two classes of photoreceptors, rods and cones, typifying a highly
specialized cell type converting light into neuronal impulses. Both cone and rod photoreceptors
consist of inner and outer segments. The inner segment is the site of metabolic processes, whereas
the outer segments are packed with the visual pigment molecules opsins (Hargrave and McDowell
1992). The rods are responsible for vision in low light conditions (night vision) and do not discern
colours. Three types of cones - short-wave or blue-, middle-wave or green-, and long-wave or red
sensitive - function in day light amplitudes and are responsible for high acuity and colour vision.
Although the human retina has more rods than cones, human vision relies upon the use of cone
photoreceptors. The most cone-rich region, the fovea, is located in the central region of the retina
(macula). The fovea is the area of the highest visual acuity in humans. In rodents the vision depends
much more on the rods. In the mouse retina, for example, two varieties of rods represent 97% of all
photoreceptors (Young 1985).
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2.2 Steps of the visual cascade
Vision begins with the reception and capture of light by the photopigments. Outer segments of
the rod photoreceptors, which are more numerous in the human retina, are relatively easy to isolate
and study. For that reason the human phototransduction scheme which is understood in detail is
light reception and processing by the rod cells. In rod photoreceptors the photons are absorbed by
the visual pigment called rhodopsin, which is embedded in the membranes of the photoreceptor outer
segments (Hargrave and McDowell 1992). Rhodopsin becomes photoexcited, and it initiates a GTP-
GDP exchange reaction with transducin (T), a GTP binding protein (Figure 2). Activated transducin
(T*) mediates the activation of cGMP phosphodiesterase (PDE). Activated PDE (PDE*) hydrolyses
cGMP leading to reduced levels of cytoplasmic cGMP. This, in turn, results in the closure of cGMP
gated channels in the plasma membrane. The closure of the channel causes hyperpolarization of the
plasma membranes and initiates the visual transduction channel signal. Re-opening of the cGMP
gated channels is caused by elevated levels of cGMP resulting from stimulation of recoverin and
guanylate cyclase (Hargrave and McDowell 1992; Shastry 1997). Similar mechanisms with different
proteins are involved in the phototransduction in cones (Peng et al. 1992).
Figure 1.  Schematic drawing of the eye (A), the retinal layers (B), and the major cell
types found in the vertebrate retina (C). Abbreviations used: RPE, retina pigmented
epithelium; PRL, photoreceptor layer; IPL, inner plexiform layer; INL, inner nuclear
layer; OPL, outer plexiform layer; ONL, outer nuclear layer; R, rod; C, cone; M, Müller
cell; H, horizontal cell; B, bipolar cell; G, ganglion cell; A, amacrine cell, I,
interplexiform cell. Photoreceptor cells have synaptic contacts with bipolar cells, which,
in turn, are in contact with ganglion cells. Horizontal and amacrine cells are mainly
responsible for the lateral pathways. Interplexiform cells carry information from inner
to outer plexiform layers. Müller cells serve a variety of functions in the retina, such as
mechanical stability, recycling of neurotransmitters, neuronal signaling, and
transmitting of nutrients to photoreceptors. Adapted from Dowling 1987.
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2.3 Genetic diseases affecting the retina
In view of the complexity of the eye, it is not surprising that the human eye is one of the most
commonest sites of genetic diseases. Hereditary retinal diseases can be further classified as
developmental anomalies, such as aniridia, which causes either absence or hypoplasia of the iris due
to PAX6 mutations (Glaser et al. 1992), and as progressive degenerative diseases, such as retinitis
pigmentosa (RP) (Humphries et al. 1992). Inherited retinal diseases are characterized by both locus
and allelic heterogeneity. Mutations in multiple unrelated genes are causing the RP phenotype (locus
heterogeneity) (Humphries et al. 1992). On the other hand, many different mutations within a given
gene can cause the same disease phenotype (allelic heterogeneity).  X-chromosomal retinoschisis is
a good example of a retinal degeneration with allelic heterogeneity (II, III, IV).
Pathologically, most retinal diseases involve either loss of photoreceptors resulting in progressive
retinal degeneration, or loss of ganglion cells leading to glaucoma and other forms of optic atrophy.
The genetic diseases affecting photoreceptors can be classified according to the type of cell that is
primarily affected (Farber and Danciger 1997). Cone-rod dystrophies (CRDs) are typically
characterized by substantial loss of cone–mediated central vision early in life. In rod-cone
dystrophies, such as RP, the main defect results from the loss of rod function. Diseases primarily
affecting rods manifest night blindness and closing of the field of vision. Inherited macular
dystrophies, which is the third class of diseases affecting the photoreceptors, often involve loss of
central visual acuity early in life. Peripheral vision, however, is typically retained longer in life
(Weber 1998). Finally, retinal degeneration and the loss of photoreceptors may be one component of
a more complex disease phenotype.
2.4 Genes causing hereditary retinal diseases
The retina-specific information network RetNet (www.sph.uth.tmc.edu/Retnet/home.htm)
provides lists of mapped and cloned genes involved in retinal diseases. In April 2000, RetNet listed
Figure 2. Schematic representation of the flow of information in the visual cascade. Modified
from Shastry 1997.
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120 autosomal, X-linked, and mitochondrial map loci for genes that are causing retinal diseases,
whereas the number of cloned genes was 56. According to RetNet statistics, the number of both
chromosomally assigned and cloned retinal disease genes has grown exponentially since the mid
‘90s (Figure 3).
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Genes involved in hereditary retinal diseases can be broadly classified into four groups: 1) those
associated in the phototransduction cascade, 2) genes of the structural components of the retina, 3)
genes affecting the RPE/photoreceptor metabolism, and 4) genes of retina (photoreceptor) specific
transcription factors (MacDonald and Sasi 1994; Gregory-Evans and Bhattacharya 1998; Sohocki et
al. 1999). Examples of genes from each category are shown in Table 1. Except for the retina specific
transcription factor genes, the list shows only a small percentage of the genes identified in each
category. Moreover, due to the high degree of heterogeneity observed with many retinal diseases it
should be emphasized that some of the diseases listed may be caused by mutations in several
unrelated genes. Leber congenital amaurosis, for example, can be caused by mutations in either
RetGC, CRX, RPE65, or AIPL1 genes (Perrault et al. 1996; Marlhens et al. 1997; Freund et al. 1998;
Sohocki et al. 2000).
Many genes causing retinal diseases show extremely restricted expression patterns, which are
controlled by specific transcription regulators (Chen et al. 1997; Martinez and Barnstable 1998;
Kobayashi et al. 1999). According to Kimura et al. (2000), at least RX and CRX transcription factors
are required for high level, photoreceptor cell restricted gene expression. Interestingly, mammalian
photoreceptors are developmentally closely related to pinealocytes (Gilbert 1994). Several genes
involved in retinal diseases, such as CRX and AIPL1, are expressed both in photoreceptors and
pinealocytes (Freund et al. 1997; Sohocki et al. 2000). Novel genes with expression patterns limited
to these two tissue types are thus potential candidate genes for hereditary retinal diseases (Sohocki et
al. 1999). Genes resulting in retinal degeneration which, in some case is a component of a more
complex phenotype, are typically widely expressed. This can be exemplified by myosin VIIA (Weil
et al. 1995), and TIMP3, tissue inhibitor of metalloproteinase-3 (Weber et al. 1994).
Figure 3. Mapped and cloned retinal
disease genes during 1980-2000. Source:
www.sph.uth.tmc.edu/Retnet/home.htm
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Table 1. Genes causing hereditary retinal diseases
Genes of the phototransduction cascade
Gene                                        Disease                                     References                    
RHO; 3q21-24 adRP, arRP Dryja et al. 1990
Gal et al. 1997
RHO; 3q21-24   congenital stationary Dryja et al. 1993
night blindness, ad
Arrestin (Sag); 2q37.1 Oguchi disease Fuchs et al. 1995
Retinal guanylate cyclase Leber congenital Perrault et al. 1996
(retGC); 17p13 amaurosis
Genes of the structural components of the retina
Gene                                        Disease                                    References                   
Peripherin/RDS; 6p21.1 adRP, digenic RP, Keen et al. 1996
severe macular diseases
RDS/ROM1; 11p13 digenic RP Kajiwara et al. 1994
RS1; Xp22.2 X-linked retinoschisis Sauer et al. 1997
PROM1; 4p16 ar retinal degeneration Maw et al. 2000
Genes affecting the RPE/photoreceptor metabolism
Gene                                        Disease                                     References                    
TIMP3; 22q13-qter Sorsby fundus dystrophy Weber et al. 1994
ABCR; 1p21-22 Stargardt macular dystrophy Allikmets et al. 1997b
(ar)
ABCR; 1p21-22 age related macular Allikmets et al. 1997a
degeneration
Retina specific transcription factor genes
Gene                                        Disease                                     References                    
CRX; 19q13 progressive cone-rod Freund et al. 1997,
dystrophy, ad cone–rod Swain et al. 1997
dystrophy (CORD2), Freund et al. 1998
Leber congenital amaurosis
PNR; 15q23 enhanced S cone syndrome  Haider et al. 2000
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3. X-chromosomal juvenile retinoschisis
3.1 Main clinical findings
X-chromosomal juvenile retinoschisis (RS, MIM312700) is a progressive vitreoretinal
dystrophy occurring almost exclusively in males. The disease was first described by Dr. Haas
(1898) more than a century ago, and it was given various names including familial neuroretinal
disease, congenital cystic detachment of the retina, and congenital vascular veils (Roesch et al. 1998).
The most characteristic clinical finding is foveal degeneration, typically leading to schisis or splitting
of the nerve fiber and ganglion cell layers of the retina (Manschot 1972; Condon et al. 1986).
Macular changes are present in all patients (George et al. 1996b). Retinoschisis cases can be further
classified to three subclasses according to the severity of the clinical features (Vainio-Mattila et al.
1969). Mild cases show retinal changes mainly in the region of the fovea, whereas in moderate cases
also peripheral changes, such as semi-translucent sail-like formations, can be seen. In the most
severe cases degenerative alterations are encountered in various layers of the retina and the choroid.
In the severely affected individuals major sight threatening complications include vitreous
hemorrhage, retinal detachment and neovascular glaucoma (Deutman 1971). Since the damage exists
in the nerve tissue, the resulting loss of visual acuity cannot be corrected by glasses. However, total
blindness is achieved only in rare cases.
Foveal schisis is most common in young patients. With age, the typical radiating striae tend
to regress leading to a blunted foveal reflex (Deutman 1971; George et al. 1996b). About 50% of RS
patients also develop peripheral schisis (Roesch et al. 1998), which may lead to formation of cysts or
holes. Cysts are characteristically arranged in a radial, cartwheel-like pattern. Other manifestations
include retinal pigmentation and vitreous body alterations (Condon et al. 1986; George et al. 1996b).
Rod function of RS patients has been reported to be impaired leading to moderately abnormal dark
adaptation (Eriksson et al. 1969). Disturbed function of the cones results in relative loss of b-wave
amplitude in electroretinogram (ERG), and in secondary colour vision disturbances (Eriksson et al.
1969). Since the b-wave amplitude reflects the activity of the Müller cells (Miller and Dowling
1970), the principal glial cells of the retina, it has been suggested that these cells are the site of the
primary defect in RS (Condon et al. 1986).
Juvenile retinoschisis is typically diagnosed during the first school years due to a decline in
visual acuity. Other early symptoms may include inability to focus both eyes on an object
(strabismus) and involuntary eye movements (nystagmus) (George et al. 1996b). Since
abnormalities of the retina have been noted in a 3-month-old male (Sieving et al. 1990), it has been
suggested that the retinal changes are present already at birth (Arden et al. 1988).
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The retinoschisis gene is fully penetrant, but phenotypic expression of the disease is variable
(Forsius et al. 1973). Age is not a factor in intrafamilial variability of the disease (Roesch et al.
1998). Reasons for differences in the phenotypic expression are so far unclear; they might be
explained by the effect of modifying genes. Heterozygous carriers of X-chromosomal retinoschisis
are symptomless, and clinical detection of the carrier state is not possible. In the literature there are a
few studies where RS carriers were reported to show either peripheral lesions or abnormal cone-rod
interactions (Arden et al. 1988; Kaplan et al. 1991). However, it is worth noting, that such features
can also be found in the eyes of normal population (George et al. 1995). A few female patients with
X-chromosomal retinoschisis have been described (Forsius et al. 1962; Uchino and Shimizu 1976;
Mendoza-Londono et al. 1999), usually as a result of consanguinity.
3.2 Geography of RS
RS has a worldwide occurrence, but it is most prevalent in Finland with a frequency greater
than 1:17 000 (de la Chapelle et al. 1994). Due to difficulties in making the  diagnosis, the disease
has been worldwidely underdiagnosed for a long time. The first patients in Finland were diagnosed
in 1962 by Dr. Forsius and colleagues (Forsius et al. 1962). The Finnish RS cases show clear
clustering to two regions. The highest prevalence of retinoschisis is found in the south-western
county of Satakunta, particularly in the parishes of Noormarkku, Pomarkku, and Lavia (Vainio-
Mattila et al. 1969). Another area with a high prevalence of RS cases is the region of Oulu in
northern Finland. Genealogical studies have failed to show any connections between the RS families
originating from these two regions (Alitalo 1990).
3.3 Previous mapping studies in X-chromosomal retinoschisis
Dr Haas, who initially described juvenile retinoschisis (Haas 1898), believed that the retinal
and choroidal changes were of inflammatory origin. The first pedigrees suggesting an X-
chromosomal pattern of inheritance were published by Pagenstecher in 1913 (Pagenstecher 1913).
The very first linkage studies were done with RS families who were typed for the XG blood group
(Eriksson et al. 1969; Ives et al. 1970). These studies showed loose linkage of RS to the XG locus.
This result was further confirmed in linkage studies by Race and Sanger (1975), Boman et al.
(1976), and Forsius and Eriksson (1980). Localization of the RS gene into the distal part of Xp was
first shown by Wieacker et al. (1983). Since the assignment of the RS gene to the short arm of the
X-chromosome, a number of linkage studies based on DNA probes recognizing restriction fragment
length polymorphisms (RFLPs) further refined the gene localization to a 7-8 cM interval flanked by
markers DXS207 and DXS43 (distally) and by DXS274 (proximally) (Alitalo et al. 1987; 1988;
Dahl et al. 1988; Sieving et al. 1990; Alitalo et al. 1991; Kaplan et al. 1991).
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In the beginning of the 1990s, the field of human linkage studies was revolutionized by
combining microsatellite markers (Tautz 1989) and PCR (Mullis and Faloona 1987). After
polymorphic microsatellite markers became available in Xp22, the localization of RS gene was first
narrowed down to 3-4 cM interval between markers DXS207 and DXS365 (Bergen et al. 1994).
Subsequent genetic mapping studies finally localized the gene to an interval of 1 cM (corresponding
to 1 Mb) between DXS418 and DXS999 (Pawar et al., 1995; Weber et al., 1995; George et al.
1996a; Trump et al., 1996; van de Vosse et al., 1996). This region was still too large for effective
positional cloning efforts, and the need for new microsatellite markers in this 1 Mb region was
obvious.
Besides the genetic mapping of X-chromosomal retinoschisis, three yeast artificial
chromosome (YAC) contigs (Alitalo et al. 1995; Ferrero et al. 1995; Van de Vosse et al. 1996) and
one P1-derived artificial chromosome (PAC) contig (Walpole et al. 1997) covering the RS critical
region have been constructed.
3.4 Identification of the retinoschisis gene
In the course of our studies directed towards the identification of the retinoschisis gene, a
novel transcript with retinal expression pattern was isolated by a German research group by the use
of the positional cloning approach. The corresponding gene, designated RS1, was shown to be
mutated in German retinoschisis patients (Sauer et al. 1997). Identification of nine different
nucleotide changes in nine unrelated families provided strong evidence that X-chromosomal
retinoschisis is caused by mutations in this novel gene.
The RS1 gene (Figure 4) consists of six exons, whose size range from only 26 bases (exon
2) up to 196 bases (exon 5). The gene has two possible polyadenylation sites, and detects transcripts
of 1.1 and 3.1 kb in Northern blots. Northern blot analyses have failed to show expression in other
tissues than retina (Sauer et al. 1997). Recently, also the murine (Rs1h) and Fugu rubripes (Fugu
XLRS1) homologies of the human gene were identified (Brunner et al. 1999; Gehrig et al. 1999a;
Reid et al. 1999). Based on in situ hybridization studies it was verified that both Rs1h and human
RS1 are expressed in rod and cone photoreceptors, but not in the other (inner) layers of the retina
(Reid et al. 1999; Trump et al. 1999).
3 4 5 61 25’ 3’
52 26 142106 196 153bp bpbp bpbp bp
0.9 kb 5 kb 1.9 kb 2.2 kb>7 kb
Figure 4. Gene structure of RS1. The alternative polyadenylation sites in the 3’
UTR are shown with arrows. According to Sauer et al. 1997.
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The retinoschisis gene encodes for 224-amino acid protein, called retinoschisin, which is
processed by N-terminal cleavage of a 23-amino acid hydrophobic leader sequence into a mature
protein of 201 amino acid residues (23 kD). The protein has an even number of ten cysteine
residues, suggesting their participation in intra- or intermolecular disulphide binding. The C-terminal
part of retinoschisin contains a discoidin (DS) domain, which is an evolutionarily conserved
structure found in several proteins (Springer et al. 1984; Sauer et al. 1997; Baumgartner et al. 1998).
No obvious homologies have been found for the N-terminal part of the protein. Recent
immunohistochemistry experiments by Trump et al. (1999) demonstrated that the RS1 gene product
can be found both in the photoreceptor cells and in the inner nuclear layer of the retina. These results
suggest that retinoschisin protein is secreted by cone and rod photoreceptors, but the actual site of
function is in the inner nuclear layers. In fact, retinoschisin is the first secreted photoreceptor protein
known to be involved in retinal degeneration.
3.5 Discoidin domain proteins
Discoidin, initially described during the cell aggregation process of the slime mold
Dictyostelium discoideum, is a lectin with high affinity for galactose. Studies of discoidin-I deficient
D. discoideum have shown that cells lose their ability to adhere and migrate, which leads to defects in
cell aggregation (Springer et al. 1984). A variety of eukaryotic proteins contain discoidin domains
(DS): many of these have tandemly repeated pairs of DS domains (Table 2). Members of the
discoidin protein family can be further classified as secreted and transmembrane proteins. Members
of this protein family typically play a role in cell-cell interactions on membrane surfaces. In addition,
they are proposed to mediate phospholipid binding (Baumgartner et al. 1998). DS domains of blood
coagulation factors V and VIII, for example, have been suggested to mediate binding of
phospholipids at the surface of platelets during blood coagulation (Kane and Davie 1988), thereby
facilitating interactions with other components of the coagulation cascade. Neuropilin, which is
expressed exclusively in the central nervous system (Takagi et al. 1991), is thought to be involved in
cell-specific synaptic contacts and development of the nervous system.
The amino acid alignment, which was done by the RS consortium (II), shows a total of 29
DS-domain containing proteins. Since then, a number of new DS-proteins from pro- and eukaryotic
species have been identified (Baumgartner et al. 1998), some of which are listed below. Human RS1-
and murine Rs1h- encoded proteins, which are almost exclusively consisting of a DS-domain, are
members of the secreted subgroup of discoidin proteins (Reid et al. 1999; Trump et al. 1999).
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Table 2. The discoidin protein family
                                                                                                                                                
Secreted        No. of DS         Function Reference
proteins                                domains                                                                                       
Blood coagulation factors 2 blood coagulation, Jenny et al. 1987,
V and VIII phospholipid binding Wood et al. 1984
Mammalian milk globule 2 phospholipid binding, Stubbs et al. 1990,
factor zona pellucida binding, Ogura et al. 1996,
O-acetyl-GD3 transferase Ensslin et al.1998
Hemocytin (Silk worm) 2 humoral lectin self- Kotani et al. 1995
defence
Retinoschisin 1 cell adhesion ? Sauer et al. 1997,
 Trump  et al. 1999
Bovine SCO-spondin 1 modulation of neural Gobron et al. 1996
aggregation
Aortic carboxypeptidase- 1 ? Layne et al. 1998
like protein 
Adipocyte transcription 1 transcriptional Ohno et al. 1996
factor repressor
                                                                                                                                                
Transmembrane              No. of DS        Function Reference
proteins                              domains                                                                                         
Neuropilin 2   calcium-dependent Takagi et al. 1991
    cell adhesion
Developmental 2   α-v β-3 integrin Hidai et al. 1998
endothelian locus-1   binding 
Neurexin IV (Drosophila) 1   cell adhesion Baumgartner et al.
1996
Contactin associated 1   cell adhesion Peles et al. 1997
protein
Discoidin domain receptor 1   cell-cell interaction Vogel 1999
tyrosine kinases (DDR1,   and recognition
DDR2)
                                                                                                                                                
Modified from Reid et al. 1999.
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3.6 Other types of retinoschisis
Juvenile retinoschisis may also show an autosomal recessive (Lewis et al. 1977; Forsius et al.
1978; Noble et al. 1978) or autosomal dominant (Yassur et al. 1982) mode of inheritance. The genes
causing these forms of juvenile retinoschisis remain to be isolated. Retinoschisis also occurs
sporadically in acquired, senile forms (also known as degenerative forms), which are considered to
be quite common among elderly individuals (Byer 1968). In a recent study by Gehrig et al. (1999b)
patients with senile retinoschisis were screened for mutations in the RS1 gene, the causative gene for
X-chromosomal juvenile RS. As no mutations could be identified, they concluded that senile
retinoschisis is not caused by germline mutations in RS1. Secondary retinoschisis (Madjarov et al.
1995), the third main class, is infrequently associated with a variety of diseases. Mechanisms causing
the secondary type of retinoschisis include intraretinal hemorrhage, vitreoretinal traction, intraretinal
exudation, and inflammation. The most common type of secondary retinoschisis is proliferative
diabetic retinopathy (Madjarov et al. 1995).
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4. Human X : an eXceptional chromosome
4.1 Sex determination and X-Y homology
The X-chromosome has many characteristic features that distinguish it from the autosomes.
Firstly, X-chromosome is one of the sex determining chromosomes. Furthermore, in mammals the
autosomes are structurally identical (homomorphic) and present in two copies. The mammalian sex
chromosomes X and Y are heteromorphic: they differ greatly from each other both in size and gene
content. However, the mammalian sex chromosomes have two regions of substantial homology. The
shared genes are located in the pseudoautosomal regions (PARs, Figure 5), which pair and
recombine in male meiosis (Rappold 1993). Elsewhere on the X- and Y–chromosomes the
possibility of recombination has been suppressed. As a result of X/Y pairing, the genes located in the
PARs are inherited in “autosomal manner”.
PAR1, 2.6 Mb
PAR2, 320 kb
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Figure 5. Pseudoautosomal genes shared by the human sex chromosomes. PAR1, located in
Xp22.3/Yp11.3, contains ten genes and 5’ part of the XGA gene. PAR2 in Xq28/Yq12 has only two
known genes. Abbreviations for the pseudoautosomal genes: CSF2RA, alpha-subunit of the
granulocyte macrophage stimulating factor; ILRA3, human interleukin receptor 3; ASMTL,
acetylserotonin methytransferase-like; ASMT, acetylserotonin methyltransferase; MIC2R, MIC2-related
locus; XGA, X -linked blood group locus, SYBL1, synaptobrevin-like gene; for the rest of the genes,
see Table 4.
The major pseudoautosomal region (PAR1) extends 2.6 Mb at the tips of the short arms on
the X and Y chromosomes (Graves et al. 1998). PAR1 contains eleven genes (Figure 5, for details
see Gianfrancesco et al. 1998; Graves et al. 1998) and is the obligate cross over site during male
meiosis. Deletion of the major pseudoautosomal region results in failure of X-Y pairing, and is
known to cause male sterility (Mohandas et al. 1992). PAR2, the minor pseudoautosomal region, is
considerably smaller (320 kb), and is located at the extremity of the long arm of X and Y
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chromosomes (Freije et al. 1992). PAR2 contains only two known genes, SYBL1 and IL9R (Renauld
et al. 1992; D'Esposito et al. 1996). Unlike the major pseudoautosomal region, cross over in the
PAR2 region is not necessary for successful male meiosis. In addition to the PARs, the human sex
chromosomes show a variety of Xp-Yq and Xq-Yp, as well Xp-Yp and Xq-Yq homologies (Guioli et
al. 1992; O'Reilly et al. 1992; Klink et al. 1995). The presence of such homologies suggests that the
X and Y chromosomes have evolved from an homomorphic autosome-like pair of ancestral
chromosomes (Ohno 1967).
4.2 Dosage compensation: 2X=1X
For any organism which has a divergent pair of sex-determining chromosomes, the resulting
difference in gene dosage between the two sexes needs to be balanced. Several different systems for
compensating the sex chromosome dosage have evolved. In Drosophila melanogaster the
transcription of the X-chromosome is doubled in males (hypertranscription) to match the level of
transcription of female chromosomes (Baker et al. 1994). The Caenorhabditis elegans XX
hermaphrodites have developed another dosage compensation system: they downregulate the
transcription from both X chromosomes to achieve equal gene dosage (Cline and Meyer 1996).
Mammals compensate the unequal number of X chromosomal genes in males and females by a
phenomenon called X-inactivation or lyonization (Lyon 1961). X-chromosome inactivation results in
transcriptional silencing of one of the two chromosomes in all somatic tissues early in female
embryonic development. The inactive X-chromosome (Xi) is also cytologically identifiable as a
condensed heterochomatin–like body (Barr body). This mechanism of dosage compensation is
unique to mammals (Latham 1996).
X-inactivation initiates from the X-inactivation center (XIC), which is located in the proximal
long arm (Xq13) of the chromosome. XIC contains a gene called XIST (X-inactive-specific-
transcript, Brown et al. 1992). XIST RNA does not encode for a protein, but plays a role in the
nucleus as a cis-acting factor spreading the inactivation signal along the X-chromosome on which it
resides (Brockdorff et al. 1992). Interestingly, the XIST gene is only expressed from the inactive X-
chromosome, but not from the active X-chromosome. Once the X chromosome is inactivated, the
inactivation status is subsequently maintained during cell proliferation by the continued expression
of XIST and by methylation of cytocine residues. Initiation of X-inactivation is random, thus
resulting in a mixture of cells that express maternally inherited X-chromosomal genes and cells that
express paternally inherited X-chromosomal genes. Methylation-based assays are commonly used
for quantification of this mosaicism (Lock et al. 1987; Vogelstein et al. 1987; Singer-Sam et al.
1990; Allen et al. 1992).
Most of the X-linked recessive disorders do not affect females although they carry one copy
of the defective allele in their genomes. This is in part due to X-inactivation: females carrying an X-
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linked mutation have in half of their cells the defective allele on the active X-chromosome, and in the
rest of the cells on the inactive one. The portion of cells with normal alleles on active X-
chromosomes is usually enough to maintain the functional activity, and spare the females from the
clinical symptoms of the X-linked disease.
4.3 Non-random X-inactivation
Occasionally, however, female carriers have clinical manifestations of an X-linked recessive
disease (Devriendt et al. 1997). This may result from severely skewed X-inactivation patterns: if
most of the cells have the X chromosome carrying the functional allele inactivated, the phenotype of
the carrier is most likely affected. Severe skewing of X-inactivation is known to occur in 3-20%
(depending on the definition and accuracy of the measurement) of the blood cells of normal healthy
females (Belmont 1996; Naumova et al. 1996; Plenge et al. 1997). The incidence of excessive
skewing increases with age (Fey et al. 1994; Busque et al. 1996) and inactivation patterns may vary
between different tissues from the same individual (Gale et al. 1994). Non-random X-inactivation
may result from several different mechanisms, which include promoter mutations in the XIST locus
leading to preferential inactivation of the X chromosome carrying the mutation (Plenge et al. 1997),
selection against cells with growth disadvantage due to deletion or mutation in one of the X-
chromosomes (Pegoraro et al. 1997), and X/autosome translocations (Gaal and Laszlo 1977).
4.4 Genes escaping X-inactivation
A number of genes escape the X-inactivation process and are expressed from both the active
and the inactive X-chromosome (reviewed in Disteche 1995). Those first discovered to escape the
inactivation process were located at, or near the pseudoautosomal region in Xp22. In fact, the lack of
inactivation of pseudoautosomal genes was expected on the basis of functional X and Y homologues
recombining during meiosis. However, not all genes escaping X-inactivation have functional Y
homologues, as exemplified by XE59 (Ellison et al. 1992), UBE1 (Coleman et al. 1996), and SB1.8
(Rocques et al. 1995). An extensive analysis of the inactivation status of 224 X-specific transcripts,
consisting of both known genes and novel ESTs (Table 3), was recently reported (Carrel et al. 1999,
also available at www.pnas.org/supplementary.shtml). According to Carrel et al. (1999), the
phenomenon of escaping X-inactivation is not rare at all, and the number of “escapees” may be as
high as one-fifth of all the X-chromosomal genes. The genes not subjected to inactivation were
mainly located in the short arm of the X-chromosome. Transcription levels for the genes escaping X-
inactivation are likely to be different in males and females, thus suggesting that gene dosage may not
be a vitally critical factor for all the X-chromosomal genes (Disteche 1995).
28
Table 3. Genes and ESTs escaping X-inactivation
Gene                            Gene product                                       Gen Bank/Uni Gene    
.
PGPL Putative GTP-binding protein Hs 101033
SHOX Homeodomain  containing protein Hs 105932
ANT3 Adenine nucleotide translocator 3 Hs 164280
DXYS155E (XE7) Lymphocyte surface protein Hs 21959
Tramp Ac-like transpoase Hs 9933
MIC2 Antigen identified by mAB 12E7, F21 and O13 Hs 118618
StSG15779 cDNA clone Hs 29952
EIF4C Eukaryotic translation initiator factor Hs 4310
StSG1369 EST Hs 5432
StSG9723 EST Hs 19978
ARSE Arylsulfatase E Hs 74131
ARDS Arylsulfatase D Hs 43887
GS1 Human Gs1 protein of unknown function Hs 78991
STS Steroid sulfatase Hs 79876
GS2 Protein of unknown function Hs 264
KAL1 Kallman syndrome 1 Hs 89591
XE57 Protein of unknown function -
CXORF5 Protein of unknown function Hs 6483
RAB9 Ras-regulated GTP-binding  protein Hs 28726
SEDT Spondyloepiphyseal dysplasia HSSEDL6
PIR Pirin Hs 38842
INE2 INE2 mRNa of unknown function Hs 13502
stSG4551 EST Hs 6716
GRPR Gastrin releasing peptide receptor Hs 73883
RBbp.7 Retinoblastoma binding protein mRNA Hs 2758
EIF2S3 Translation initiation factor subunit Hs 211539
ZFX Zinc finger protein, X-isoform Hs 207
CRSP2 Cofactor required for Sp1 transcriptional initiaton Hs21586
USP9X Ubiquitin specific protease 9, X isoform Hs 98296
ZNFXP Xp homologue of ZNF127 -
UTX Ubiquitous TPR motif, X isoform z24913
UBE1 Ubiquitin-activating enzyme E1 subunit Hs 2055
PCTK1 PCTAIRE-1 serine-theorine protein kinase Hs 171834
INE1 EST Hs 199245
SMCX X homologue for H-Y antigen Hs 180756
ADS56 EST Hs 069136
DXS1000E EST Hs 069137
RPS4X Ribosomal protein S4, X isoform Hs 75344
WI-12682 EST Hs 108029
IL9R Interleukin 9 receptor precurson gene Hs 1702
                                                                                                                                    
Data according to Carrel et al. 1999. Gene symbols in bold denote
pseudoautosomal  genes.
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5. Disease gene identification
5.1 Cloning approaches
A variety of different methods are available for disease gene identification (Figure 6, Collins
1992; Collins 1995). In functional cloning, no information of the chromosomal location of the
disease locus is needed. Identification of the gene depends upon fundamental biological information,
such as the basic biochemical defect of the disease. Disease genes identified via classical functional
cloning approach include the gene for hyperornithemia with gyrate atrophy of the choroid and retina
(OAT, Mitchell et al. 1988), the gene for Finnish type of familial amyloidosis (gelsolin, Maury et al.
1990), and the aspartylglucosaminidase gene (AGA, Ikonen et al. 1991). Although being an effective
approach in disease gene identification, it is clear that this traditional form of cloning had its golden
age during the early days of the Human Genome Project.
Positional cloning, in contrast, refers to isolation of the disease gene on the basis of its
genetic or physical location in the genome. In most cases the positional cloning approach is the only
possibility to find the gene responsible for a given inherited trait. The X-chromosomal genes
causative for chronic granulomatous disease (Royer-Pokora et al. 1986) and Duchenne muscular
dystrophy (Monaco et al. 1986) were the very first human genes identified by positional cloning.
Examples of “Finnish disease genes” identified by pure positional cloning include DTD,
(Hästbacka et al. 1994), AIRE (The Finnish-German APECED Consortium. 1997), NPHS1 (Kestilä
et al. 1998), RS1 (Sauer et al. 1997), and CHM (Cremers et al. 1990). Cloning of CHM, the gene
causing choroideremia, was aided by detection of chromosomal deletions in some of the patients.
Deletions and other types of chromosomal rearrangements in affected individuals may offer valuable
shortcuts for a positional cloner (Francke et al. 1985).
Nowadays, positional cloning in its purest form is often replaced by the more efficient
positional candidate approach (Ballabio 1993). This method combines knowledge of the
chromosomal location of the disease locus with the human transcript map of increasing density
(Deloukas et al. 1998). Once the map position of the gene of interest is resolved, other genes
mapped to this critical region should be considered as potential candidates. Ideally, one of the
positional candidates is also functionally attractive. The final identification of the two pieces in the
puzzle can be aided by comparisons of additional features of the disease with some specific features
in the candidate gene (such as imprinted inheritance - imprinted expression, developmental defect -
developmentally controlled gene expression, disease showing anticipation - sequence instability).
The efficiency of this cloning approach is greatly contributed by recent advances in mapping and
identification of short stretches of cDNAs throughout the human genome. When sequenced, these
short cDNAs generate expressed sequence tags (ESTs); small stretches of anonymous human genes
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localized in specific chromosomal regions (Adams et al. 1991). EST databases are currently
expanding at enormous rates (www.ncbi.nlm.nih.gov./dbEST), and it has been postulated that most
(if not all ) of the human genes are already present in the databases (Rowen et al. 1997). Examples
of “Finnish disease genes” identified by positional candidate approach are numerous (FSHR,
Aittomäki et al. 1995; PPT, Vesa et al. 1995; CUBN, Aminoff et al. 1999; etc.). Finally, in the
position-independent candidate gene approach (Collins 1995), a candidate gene can be suggested
without any knowledge of its chromosomal location. Identification of the candidate may result from
studies on homologous genes coding proteins in related illnesses.
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5.2 Polymorphisms as genetic markers
The first step in a positional cloning project is to map the disease locus to a subchromosomal
region. This is done by studying the segregation of alleles at polymorphic marker loci in families
with affected individuals. The uniqueness of each human being is based on the high degree of DNA
sequence variation between individuals. This variability, mostly occurring in the non-coding regions
of the genome, is called polymorphism. When inherited in the Mendelian fashion, the
polymorphisms can be utilized as genetic markers (Botstein et al. 1980). Different types of
polymorphisms which can be utilized as genetic markers are presented in Table 4. The first
generation genetic markers were single nucleotide variation based restriction fragment length
polymorphisms (RFLPs), which can be caused either by single nucleotide substitution, or by
insertion or deletion of a few nucleotides. However, RFLPs suffered from relatively low information
content and laborious detection methods,  and they were soon replaced by minisatellite-, and later by
microsatellite markers, offering considerably higher polymorphism information content (PIC)
–values.
The usefulness of any type of polymorphism in genetic mapping was greatly expanded by
the introduction of the polymerase chain reaction in the late 1980s (Mullis and Faloona 1987). In the
case of RFLPs, the sequence which includes the two-allele restriction site polymorphism can be
Figure 6. Methods of disease  gene identification.
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amplified by PCR, digested with the appropriate restriction enzyme, and analyzed by gel
electrophoresis. Mini- and microsatellites are amplified utilizing the unique sequences surrounding
these polymorphic regions. Amplification by PCR is followed by polyacrylamide gel electrophoresis
to size fractionate the different alleles.
Table 4.  Different types of polymorphisms and their main features.
                                                                                                                                    
Type of Frequency in Main advantage
polymorphism                         the genome                                                                  
Single nucleotide 3 to 50 per 10 kb High frequency,
polymorphisms low mutation rate
(SNPs, including RFLPs)
Minisatellites Less common than  Multiallelic
(VNTRs) microsatellites
Microsatellites 1 per 30 kb  Highly informative
                                                                                                                                    
Type of Main  disadvantages References
polymorphism                                                                                                             
Single nucleotide Often biallelic, Botstein et al. 1980
polymorphisms laborious detection
(SNPs, including RFLPs) before  PCR
Minisatellites                Uneven distribution in the Jeffreys et al. 1985
(VNTRs) genome, laborious detection
before  PCR
Microsatellites High mutation rate Tautz 1989,
Weber and May 1989
                                                                                                                                    
Quite recently, the focus has turned back to the use of single nucleotide polymorphisms.
This is mainly due to their great potential for automation, such as DNA chip technology. Although
being biallelic by nature, low mutation rates and dense distribution through the genome make them
attractive for today’s mapping purposes (Wang et al. 1998). Moreover, SNPs have an extra
advantage: they can be found both in coding (cSNPs ) and noncoding regions (Collins et al. 1997).
5.3 Principles of  linkage analysis
When two genetic loci are inherited together more often than expected by pure chance, they
are said to be linked. Linkage between these loci results from their location on the same
chromosome: two loci located near each other are only seldom separated due to recombination events
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during meiosis. The likelihood of recombination between two loci is measured by recombination
fraction (θ). The unit for measuring distances between genetic loci is centiMorgan (cM),
corresponding to a recombination fraction of 1% (0.01). This means that two loci, which are
separated by 1 cM genetic distance, have 1% chance of recombination during meiosis. An average
measure of 1 cM equaling to 1Mb can be used in comparisons between genetic and physical maps.
However, since recombinations occur almost as twice as often in oocytes than in spermatocytes, the
average female genetic map is about 40% longer than in males (Gyapay et al. 1994). Moreover, the
frequency depends on the nucleotide sequence and notable variations exist between different
chromosomal areas.
Statistical significance in linkage analysis is typically estimated by the logarithm of odds
–ratio (Lod score, Morton 1955). The likelihood ratio is obtained by calculating the likelihoods on
two alternative assumptions. Firstly, under the assumption that the loci are linked with a given
recombination fraction (θ), and secondly, under the assumption that they are not linked (θ=0.5) (Ott
1974; Lathrop et al. 1984; 1985; Ott 1989). In linkage analysis, this ratio is calculated at different
recombination fractions. When the lod score reaches its maximum value, the corresponding
recombination fraction denotes the most likely distance between the loci studied. Significant evidence
for linkage between two genetic loci is assumed when the lod score reaches the value 3  (≥ 3).
5.4 Linkage disequilibrium mapping
Linkage disequilibrium (LD), the non-random distribution of alleles at given loci, is a
powerful tool for positional cloning of disease genes whenever the population under study fulfills
certain prerequisites. The population should derive from a relatively small number of original settlers
(founders) and the major disease causing mutation should originate from a single ancestor. On the
other hand, the present population must be large enough to provide an adequate number of disease
and normal chromosomes for the analysis. This expansion should have occurred by population
growth instead of immigration. Finally, the time period elapsed since occurrence of the mutation
should be sufficiently long to allow recombinations to narrow the region of strongest disequilibrium
(de la Chapelle 1993; Jorde 1995; Peltonen et al. 1995;  de la Chapelle and Wright 1998).
In founder populations linkage disequilibrium mapping is based on the assumption that
disease chromosomes descending from the same ancestor share a common haplotype in close
vicinity of the disease gene (Jorde 1995). In other words, the combination of alleles seen in affected
individuals living in the 21th century should reflect the allele combination of the founder
chromosome. The length of the chromosomal region showing LD depends on the age of the
mutation, and on the recombination frequency of the region under study (Peltonen et al. 1995).
Today, a number of nonparametric statistical tests are available for estimating the strength of allelic
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association. The likelihood method, introduced by Terwilliger in 1995, tests linkage disequilibrium
simultaneously for several marker loci (Terwilliger 1995). Similarly, modified formulas for
estimating distances between the disease gene and different marker loci have been introduced. The
well-known example is the adaptation of a derivative of the Luria and Delbrück’s (1943) classical
method, originally developed for mutation rate analysis in exponential bacterial cultures. This
methodology was first utilized by Hästbacka et al. to pinpoint the localization of the DTD gene
(1992).
5.5 Physical mapping
Once the gene of interest has been assigned to a subgenomic region, the next task is the
construction of a physical map. Genomic clones with overlapping human DNA inserts serve as
building bricks in physical map assembly. Cosmids (Collins and Bruning 1978) were the very first
tools for physical mapping and contig construction. However, the small insert size (40kb) and clone
instability reduced their usefulness in mapping of complex genomes. Yeast artificial chromosomes
(YACs), developed in the 1980s (Burke et al. 1987), were the first large-scale clones available for
physical contig construction. Although YACs with very long human DNA inserts proved to be
suitable for establishing coverage for large genomic regions, the problem of frequent chimerism (i.e.
the presence of discontinuous regions) soon arose. Today, the most commonly used vectors include
bacteriophage P1 based vectors (Pierce and Sternberg 1992), P1 artificial chromosomes (PAC,
Ioannou et al. 1994), and bacterial artificial chromosomes (BAC, Shizuya et al. 1992). P1, PAC, and
BAC vectors are propagated in bacterial hosts enabling easier DNA manipulation than in yeast cells.
Ordering and size estimation of clones is typically done by STS content mapping and
restriction mapping. Sequence tagged sites (STSs, Green and Green 1991) can be generated from
the ends of YAC clones via ligation mediated PCR (Kere et al. 1992), or by direct sequencing of
bacterial clone ends. Restriction mapping of long–range clones (Brown and Bird, 1986) is based on
restriction enzyme digestions followed by size fractionation by traditional or pulsed field
electrophoresis (Schwartz and Cantor 1984), depending on the insert size. Restriction mapping
reveals possible deletions or duplications present in the clones. Other alternatives for contig
characterization include radiation hybrid mapping (Cox et al. 1990) and fingerprinting (Evans 1991).
Finally, fluorescence in situ (Pinkel et al. 1986) based “visual mapping” techniques with different
resolutions facilitate mapping over distances ranging from megabases (metaphase chromosomes) to
a few kilobases (fiber-FISH, reviewed in Heiskanen et al. 1996).
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5.6 Identification of expressed  gene  sequences  
By combining both genetic and physical mapping techniques it is usually possible to restrict
the disease gene critical region down to 500 kb, a region which is feasible for candidate gene
identification strategies. The methods available for transcript identification can be classified as cDNA
based methods, and as methods based on the use of genomic DNA. However, none of the techniques
offers 100% reliability of identifying all the genes in the region. Thus, the use of at least two
complementary techniques is advisable.
Most commonly used cDNA based methods, also referred to as expression dependent
methods, are direct cDNA library screening, cDNA selection (Lovett et al. 1991; Parimoo et al.
1991), and Northern blot hybridization (Lehrach et al. 1977). cDNA selection involves hybridization
of target DNA, such as YACs, PACs, or cosmids, to a mixture of cDNAs (typically to a cDNA
library). Several rounds of elutions, amplifications, and hybridizations lead to the enrichment of
desired cDNA sequences. cDNA based methods may turn to be difficult if the gene under study has
very low expression levels, typically due to strictly limited expression to a certain cell type or
developmental stage. Since the quality of source cDNA is crucial, the presence of any contaminant,
such as genomic DNA, should be avoided.
The methods based on genomic DNA, or expression independent methods, include CpG
island identification (Bird 1986; Larsen et al. 1992), exon trapping (Auch and Reth 1990; Duyk et al.
1990), zoo-blots (Claudio et al. 1994), and genomic sequencing. CpG islands, unmethylated GC-rich
sequences, are typically found near the 5’ ends of vertebrate genes, and can serve as landmarks in
gene identification (Larsen et al. 1992). It must be noted, however, that only 56% of human genes are
associated with CpG islands (Antequera and Bird 1993), thus leaving out a substantial number of
genes which can not be found using this method. Exon trapping – in vitro identification of splicing
sites – utilizes eukaryotic splicing machinery for identification of exon sequences in cloned genomic
DNA. The major disadvantages in exon trapping are the occurrence of cryptic splice sites at a
relatively high frequency, and the relatively small size of the trapped exons. New, modified vectors
have been introduced to overcome the problems of false positive results due to cryptic splicing, as
well as the problem of the small size of trapped products (Burn et al. 1995; Datson et al. 1996). Zoo-
blots are widely used to demonstrate the evolutionary conservation between gene families and
conserved protein motifs
5.7 Sequence databases and  in silico cloning
The exponential growth rate of nucleotide sequence data available in various databases has
been revolutionizing in the field of molecular biology. The rapid growth of databases, such as
GenBank which is doubling every 15 months (Benson et al. 1999), results mainly from the ongoing
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large-scale sequencing projects. However, keeping in mind that only 3% of the human genome is
expected to be coding, struggling through billions of bases in order to identify the genes is a huge
task for any researcher. Fortunately, along with the expansion of databases, also a growing number
of computer-based programs have became available. These algorithms are commonly used for
evaluation of biologically relevant signals (open reading frames, conserved sequences at exon-intron
boundaries, splice sites) present in the nucleotide sequences (for reviews of computational methods
available see Claverie 1997 and Borsani et al. 1998). Indeed, the recent developments in the field of
bioinformatics, including both the enormously expanding databases and the sophisticated computer-
based gene identification methods, have lead to in silico or “cybercloning”. Careful computer aided
analysis in a traditional gene-hunting project may reduce significantly the required amount of lab
work. Identification of the CLN5 gene,  causative for Finnish variant of late infantile neuronal ceroid
lipofuscinosis, utlized both traditional positional cloning methods and computational gene
identification methods (Savukoski et al. 1998).
5.8 Mutation identification : Unknown mutations
Once a good candidate gene for the disease under study is identified (based on positional or
functional candidacy), it must be tested to prove that the gene is associated with the disease. The
methods for testing candidate genes are numerous, and only the most commonly used ones are
discussed here. Detailed descriptions of mutation detection methods are given by Cotton (1993) and
Landegren (1996) .
Southern blot hybridizations (Southern 1975) may be used for detecting deletions and other
types of genomic DNA rearrangements. Hybridization of RNA blots (Northern blots, Lehrach et al.
1977) will reveal the possible transcription level changes. However, tissue specific expression of the
candidate gene limits the use of Northern blot analysis as a tool for mutation detection. This is due to
the fact that patient RNA is typically available only from lymphoblasts or skin fibroblasts. Direct
sequencing may offer a rapid way for testing the candidate gene in the initial stage.
Single strand conformation polymorphism (SSCP) analysis (Orita et al. 1989) is one of the
most commonly used methods in mutation screening. SSCP is based on mutation-induced changes
in the tertiary structure of single stranded DNA. These changes cause mobility shifts in non-
denaturing PAGE electrophoresis. The sensitivity of this method decreases with increasing fragment
length. Another common choice for mutation screening is denaturing gradient gel electrophoresis
(DGGE, Lerman and Silverstein 1987). DGGE identifies mutations on the basis of altered melting
properties; mutation containing DNA duplex will show different melting temperature when
compared to the wild type DNA duplex. Both SSCP and DGGE share two major disadvantages.
Firstly, they don’t reveal the exact position and nature of the mutation causing the mobility shift or
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altered melting temperature, and therefore they need to be combined with sequencing. Secondly, the
mutation detection sensitivity of these methods is not 100%. Enzyme mismatch cleavage (EMC,
Youil et al. 1995) and chemical cleavage methods (CCM, Cotton et al. 1988) are based on
mismatched bases in heteroduplex molecules, which are sensitive to cleavage by chemicals or
enzymes. EMC and CCM provide more precise data than SSCP or DGGE because cleavage occurs
at, or close to, the specific mutation.
After identifying a nucleotide change in the candidate gene, the possibility of a neutral
sequence variant, i.e. a polymorphism, must be ruled out by screening an adequate number of control
individuals. Moreover, when assessing the real significance of a newly identified nucleotide change,
segregation of the alteration in the families according to the mode of inheritance must be analyzed.
Further evidence for the pathogenic nature of a given mutation can be gained by functional studies,
provided that the function of the protein is known.
5.9 Screening of known mutations
In principle, screening of a known sequence alteration can be done by any of the mutation
detection methods available. Whenever the detected mutation hits the recognition sequence for a
restriction enzyme, a simple PCR/restriction enzyme detection method can be designed (II, III). An
artificial diagnostic restriction site can also be introduced by PCR mutagenesis. Allele-specific
oligonucleotide analysis (ASO, Conner et al. 1983) is a targeted mutation detection method based on
decreased binding between oligonucleotide and the mutation containing DNA molecule. Under
stringent hybridization conditions the synthetic probe will hybridize only to a perfectly matching
sequence. OLA (oligonucleotide ligation assay, Nickerson et al. 1990) based detection of single
nucleotide changes requires two oligonucleotides that hybridize to adjacent sites in the target DNA.
DNA ligase will join these two oligonucleotides only if they match perfectly to the target molecule.
Allele specific amplification (ASA, Newton et al. 1989) utilizes primers that differ at the
extreme 3’ terminus, because successful PCR amplification depends on correct base-pairing at the
3’ end. The 3’ mispairing of allele-specific primer prevents the amplification of either a wild-type or
mutant allele. A modification of ASA, TaqMan-ASA (Fujii et al. 2000), exploits the 5’->3’
exonuclease activity of Taq DNA polymerase (Holland et al. 1991). TaqMan-ASA involves the
hybridization of three primers: the third primer cannot prime DNA synthesis but carriers two
fluorogenic groups with different wavelengths,  a reporter and a guencher. During PCR amplification
Taq polymerase synthesizes the new strand until the enzyme reaches the third primer, which is
degraded by the 5’->3’ exonuclease activity. As a result, the two fluorochomes are no longer bound
to the same molecule. This results in an increase in the reporter emission detection, and allows real-
time monitoring of the efficiency of amplification.
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In solid phase minisequencing (or single nucleotide primer extension, Syvänen et al. 1990;
1993) a detection primer anneals to target DNA (both mutant and wild-type alleles) in the close
vicinity of the variable nucleotide. DNA polymerase synthesizes new DNA strand and incorporates a
labeled nucleotide which is complementary to the nucleotide to be detected. The method for
quantitative detection of mutant and wild-type alleles depends on the label used (radioactive or
fluorescent label). Solid phase minisequencing offers excellent resolution between heterozygous and
homozygous genotypes, and it is relatively insensitive to minor changes in the reaction conditions.
Furthermore, the method offers possibilities for multiplex assays, i.e. simultaneous detection of
many SNPs per sample in an oligonucleotide array format (“DNA  chip”) (Pastinen et al. 1997).
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AIMS OF THE PRESENT STUDY
The main goal of this study was to provide basic information for understanding the molecular
pathogenesis of X-chromosomal juvenile retinoschisis (RS). This knowledge may help to provide
new strategies for treatment of the disease, and may also help the studies of other forms of retinal
degeneration.  The studies I -V were carried out to
1. Refine the critical RS region in Xp22 (I)
2. Establish a physical map across the critical region to provide tools for candidate gene isolation (I,
unpublished)
3. Identify the disease causing mutations in Finnish and foreign patients (II, III, IV)
4. Develop methods for diagnostic RS mutation detection in Finland (III)
5. Confirm or contradict whether the secondary sex ratio is truly skewed in the offspring of carriers
of the Western I mutation (V)
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MATERIALS AND METHODS
1. RS families and control individuals
Initially, 31 Finnish RS families with 100 affected males and one affected female were
included in the study. The pedigrees of these families were previously published (Alitalo 1990).
During the course of the study,  the family material was supplemented by 24 new patients. Except
for one patient, all Finnish RS cases were familial. In addition, we received DNA samples from 26
foreign RS patients (16 patients from Denmark, 3 from Sweden, 1 from Iceland, 1 from UK, 3 from
Scotland, and 2 from the USA). DNAs from healthy blood donors from western and northern
Finland were used as control individuals (Alitalo et al. 1991). For the secondary sex ratio studies, we
collected blood samples from 64 potential RS carriers who had not taken part in our previous
studies.  
2. DNA and RNA extraction
High molecular weight DNA was extracted from blood leukocytes or cultured lymphoblasts
using a non-enzymatic, high salt based method (Lahiri and Nurnberger 1991). Total RNA isolation
from cultured lymphoblasts and fibroblasts was performed with Qiagen RNeasy kit according to the
manufacturer’s instructions.
3. Isolation of novel microsatellite markers
Novel polymorphic CA/GT-repeats were screened as follows. Eighteen cosmid clones and
three PAC clones were obtained by hybridizing the ICRF reference library with YAC 1774 (cosmids
filters) and YAC specific end fragments (PAC filters). Cosmid and PAC DNAs were digested with
HindIII and EcoRI, size fractionated on agarose gels, and transferred to nylon membranes (Hybond-
N). Membranes were hybridized with radiolabelled poly[d(C-A)n] oligonucleotide probe in standard
hybridization solution at +65ºC. After high stringency washes membranes were exposed to X-ray
films for 1-4 days. Clones with positive signals were further digested with Sau3A1 and subcloned
into BamHI sites on pBluescript vector. Ligation mixture was transformed into E. coli XL-1 Blue
strain, and plated on selective agarose plates (LB+ampicillin 50µg/ml). Plasmid DNA was extracted
from recombinant pBluescript-clones, and the CA/GT-positive clones were sequenced.
Oligonucleotide primers flanking novel repeats were designed using the Primer 3 program (www-
genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi). Allele sizes and frequencies for the novel
markers were determined by genotyping 100 control X-chromosomes.
4. Genotyping
Polymorphic microsatellite markers were amplified by PCR (Mullis and Faloona 1987), and
the amplified products were fractionated on 6% polyacrylamide gels. The gels were visualized by use
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of a modified silver staining protocol (Bassam et al. 1991). The detailed reaction conditions for the
amplification of microsatellite markers using PCR are described in each of the original publications.
5. Linkage analysis
Linkage analysis was performed by use of the LINKAGE program package (Lathrop et al.
1984). Pairwise lod scores were calculated using the MLINK, and multipoint linkage analyses were
performed with the LINKMAP option. Linkage analyses were performed assuming X-chromosomal
recessive mode of inheritance, and complete penetrance of the gene in individuals hemizygous for the
disease allele. The estimated gene frequency was 0.001, and the estimated mutation frequency
0.000001. The allele frequencies of DXS9911 and DXS9912 were those obtained from the Finnish
blood donors (I). For the other markers, we used published allele frequencies
6. Linkage disequilibrium and haplotype analysis
For the purpose of linkage disequilibrium, we first examined each marker locus separately
for an increased frequency of a certain allele by using the Fisher’s exact test. Bonferroni correction
was applied to compensate for multiple testing. The genetic distance between close markers and RS
gene mutation was estimated using a modification of the Luria-Delbrück calculation (Hästbacka et al.
1992; de la Chapelle 1993; Lehesjoki et al. 1993). Allelic excess (denoted by Pexcess) was calculated
using the formula Pexcess = (Paffected-Pnormal)/(1-Pnormal), where Paffected is the frequency of the allele
associated with the RS chromosomes and Pnormal is the frequency of that in the control
chromosomes. Finally, the DISMULT program (Terwilliger 1995) was used for linkage
disequilibrium analysis for multiple loci jointly. The haplotypes for the disease-bearing
chromosomes and for the healthy chromosomes were constructed manually.
7. Physical mapping
7.1 Yeast artificial clone contig and restriction mapping
In addition to six yeast artificial clones (YACs) from a previously published YAC contig
(Alitalo et al. 1995) new clones were screened from the St. Louis library (Nagaraja et al. 1994) and
the ICRF library (Albertsen et al. 1990). DNA from YACs was prepared in agarose blocks
according to Scherer and Tsui (1991). Sizes of the YAC clones were determined by pulsed-field gel
electrophoresis followed by Southern blotting (Southern 1975) and hybridization with total human
genomic DNA. End fragments of the new YACs were isolated by ligation mediated PCR (Kere et al.
1992). The isolated end fragments were sequenced to obtain new STSs into the RS critical region.
The order and orientation of the clones were resolved on the basis of their STS content and
restriction mapping.
Altogether nine YACs, whose sizes range between 170 kb and 1310 kb (Alitalo et al. 1995, I)
were included in the restriction mapping. Restriction maps were constructed by digesting agarose
41
block DNA with rare-cutter restriction enzymes. Fragments were separated by pulsed-field gel
electrophoresis (Chu et al. 1986) using a Bio-Rad CHEF DR II apparatus under conditions that
fractionate the DNA from 50 to 1500 kb. The pulsed-field gels were acid nicked and DNA was
transferred to nylon membranes (Hybond N). Membranes were hybridized with 32dCTP labelled
vector specific probes (pUC18 and 1.0 kb AvaI-BamHI fragment of pBR322), and with some of the
isolated YAC-end fragments. Hybridization conditions were as described above.
7.2 Cosmid contig
The linkage disequilibrium studies suggested that the RS gene is most likely located between
the markers DXS418 and DXS9911 (I). Although this 300 kb interval was covered with a single
YAC (YAC 1774), we constructed a cosmid/PAC contig in order to provide better tools for candidate
gene isolation. A total of twelve ICRF cosmid clones, previously assigned to this region by screening
with YAC 1774, were cultured in LB medium supplemented with kanamycin (50 µg/ml). In addition,
one PAC clone obtained with STS 1774L, was included in the contig. Cosmid and PAC DNA was
extracted with Qiagen Mini kit. Insert ends from nine cosmids were sequenced with T7 and SP6
universal primers present in the lawrist 4 vector. New STSs were designed based on the sequence,
and order and orientation of cosmids were resolved by STS mapping.
8. Large scale sequencing and sequence analysis
Large scale genomic sequencing of the ~1 Mb retinoschisis region was done at the Sanger
Center (Cambridge, UK) based on the PAC clones provided by the Retinoschisis consortium. The
sequence data produced during the collaboration of the Retinoschisis consortium are available at
Sanger Center www-pages (www.sanger.ac.uk.) As soon as the novel sequence from the RS critical
region became available, novel di-, tri-, and tetranucleotide repeats were obtained simply by visual
screening of the sequence. Primer design and determination of the allele sizes and frequencies was
done as described above. The novel sequence was analyzed by GRAIL (www.avalon.epm.
ornl.gov/Grail-bin/ EmptyGrailForm) to predict the potential exons in the region.
9. Mutation analysis
9.1 SSCP analysis
The GRAIL predicted exons were amplified from RS patients and control individuals.
Amplified products were separated on 0.7-1x MDE gels (Mutation Detection Enhancement, FMC).
Gels were run at room temperature with 10 W constant power for 14-20 hours and visualized by a
modified silver staining protocol (Bassam et al. 1991). PCR fragments with aberrant SSCP patterns
were sequenced in both directions by fluorescent automated sequencing. Similarly, after
identification of the RS1 gene (Sauer et al. 1997) mutations in Finnish and foreign patients were
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screened by SSCP analysis. For the RS1 specific PCR, we used primer sequences and conditions
published by Sauer et al. (1997).
9.2 Restriction enzyme based mutation detection
After the initial identification of the most common Finnish RS1 mutation (214G>A) by
SSCP and sequencing, subsequent screening of the mutation was done by the PCR/restriction
enzyme based method. This was based on the loss of a TaqI site generated by the G to A change
(TC G/A AG) on the mutated allele. Genomic PCR fragments were digested in 25 µl total volume
including 5 µl of the PCR product, 10 U of TaqI and 1x respective digestion buffer. The digestion
products were separated on 1.5% agarose gels and stained with ethidium bromide.
9.3 RFLP analysis
In studies II and IV RS patients and control individuals were analyzed by RFLP to detect
large genomic rearrangements. Genomic DNA (10 µg) was digested, size fractionated on 1%
agarose gels, and transferred to nylon membranes (Hybond-N) by Southern blotting (Southern
1975). Membranes were hybridized with radiolabelled RS1 exon 1 or 5’ UTR specific probes as
described above. The presence of restriction fragment polymorphism was assessed by comparison
of hybridization signals between patients and controls.
9.4 Genomic walking
For detailed characterization of the genomic deletions identified, we used a PCR-based DNA
walking method (Genome Walker kit, Clontech, Siebert et al. 1995). Briefly, patient DNA was first
digested with restriction enzymes EcoRV, ScaI, DraI, PvuII, and StuI, and ligated to adaptors in order
to construct five different libraries. Two gene specific primers (GSP1 and GSP2) were designed
based on the sequence from the non-deleted region close to the deletion breakpoint. Primary and
secondary amplifications in each library were performed with GSP1/GSP2 and AP1/AP2 primers,
and Advantage-2 polymerase (Clontech) according to the manufacturer’s instructions. Secondary
PCR products were purified and sequenced using GSP2 as the sequencing primer. To facilitate
DNA walking along the uncloned region, new gene-specific primers were designed based on the
sequence
10. Secondary sex ratio (SSR) studies
The SSR was determined for the Western I mutation carriers and their healthy sisters. First,
the carrier status of 202 females belonging to Western I pedigrees was analyzed by TaqI -based
mutation detection method (III). Carriers of the Western I  mutation (n=149) were then divided into
two groups (truncated and untruncated) based on how they were ascertained. Finally, the SSR was
calculated from the truncated and untruncated offspring data of Western I carriers, and from the
offspring data of their non-carrier sisters according to the mathematical formulas introduced by
Fellman et al. (1999). The normal, expected  SSR value was obtained from the Official Statistics of
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Finland (1997). In addition, the figures from the non-carrier offspring data were used as normal
values.
11. RS1 gene expression analysis:  cDNA synthesis and RT-PCR
Total RNA (0.5 µg) was used as a template for cDNA synthesis. cDNAs were synthesized
in 20 µl reaction mixtures containing 10 pmol of random hexamers, 0.25 mM of each dNTPs, 20 U
RNasin ribonuclease inhibitor (Promega), 200 U M-MLV reverse transcriptase (Promega), and 1x
respective buffer. For the RS1 specific PCR, cDNAs were amplified by a nested PCR strategy to
enhance yield and specificity. In the first round, 1 µl of newly synthesized cDNA was used as a
template in 25 µl PCR reaction. For the second round, 5 µl of 1:100 dilution of the first round
product was used as a template. PCR conditions and primer sequences were as described in V. As a
result of the nested RS1 specific PCR, a product of 668 bp was obtained. Equal loading of each
cDNA was controlled by β-actin specific PCR.
12. X-inactivation analysis
The overall X-inactivation status of RS carriers and control females was determined by PCR
analysis of a polymorphic repeat in the human androgen receptor (AR) gene. Methylation close to
this repeat has been found to correlate with X-chromosome inactivation (Allen et al. 1992). The
inactive X chromosome is methylated and thus resistant to cleavage by HhaI, and amplification is
obtained from the inactive X chromosome only. The PCR products were separated on an automated
sequencer (ABI 373) and analyzed by GeneScan software. The X-inactivation patterns were
classified as random, moderately skewed, skewed, and extremely skewed according to Plenge et  al.
(1999).
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RESULTS AND DISCUSSION
1. Refined localization of the RS gene (I, III)
1.1 Genetic mapping
1.1.1 Linkage studies and recombination mapping (I)
Prior to starting the genetic and physical mapping studies presented in this thesis, the RS
locus had been assigned to an interval of ~1 Mb between the markers DXS418 and DXS7161
(Dumur et al. 1995; Pawar et al. 1995; Weber et al. 1995; Van de Vosse et al. 1996; Trump et al.
1996). This interval was still too large for effective positional cloning attempts, and it was necessary
to determine the location of the gene locus more precisely. Therefore we proceeded with isolation of
new microsatellite markers from cosmid and PAC clones covering the RS critical interval. Two of the
new microsatellite markers identified, DXS9911 (HYAT1) and DXS9912 (HYAT2), were
polymorphic with heterozygosity values of 0.74 and 0.10, respectively. A third microsatellite marker
(HYAT3) was not informative in our family material, and the fourth (O03240/CA12) turned out to
originate from a chimeric PAC clone and was thus rejected. However, DXS9912 was not used in the
subsequent linkage studies due to its low heterozygosity value.
Multipoint linkage analysis was performed with RS and markers DXS43, DXS418,
DXS9911, DXS999, DXS7161, DXS274, and DXS365, with intermarker spacings of 0.1 to 1.0 Mb
(for individual distances see I). We were not able to find recombinations between
DXS9911/DXS9912 and the RS locus. Multipoint analysis gave a maximum lod score of 31.3 for
the RS locus being located in the interval between DXS418 and DXS7161. This result was
consistent with the linkage data obtained by other groups (Dumur et al. 1995; Pawar et al. 1995;
Weber et al. 1995; Van de Vosse et al. 1996; Trump et al. 1996).
1.1.2 Haplotype analysis with the basic marker set favours the hypothesis of two founder
mutations (I)
On the basis of the earlier RFLP-based haplotypes and genealogical studies (Alitalo 1990;
Alitalo et al. 1991) it could be assumed that there are two prominent RS founder mutations in
Finland. In those studies, 76% of the western, and 75% of the northern patients shared a common
haplotype (the suggested western and northern founder haplotype) over the 11cM region studied.
Also the haplotype data obtained with the markers DXS43, DXS1195, DXS418, DXS9911,
DXS999, DXS7161, DXS365, and DXS274 favoured the hypothesis of two independent founder
mutations in the Finnish RS patients. In this study all the northern RS patients showed a conserved
haplotype spanning the ~1 Mb DXS418-DXS7161 critical region. Among the western RS cases,
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80% of the patients shared a common haplotype over the DXS418-DXS7161 interval. None of the
RS associated haplotypes were present in healthy chromosomes. In addition to the conserved
western and northern allele combinations, we detected four clearly distinct haplotypes. Three of these
(nd-1-8-5-5-6-6-nd, 1-1-7-5-7-2-nd-1, and 1-2-9-6-9-2-1-1) occurred in individual families and one
(1-3-8-7-1-5-6-1) in three families, suggesting the segregation of unique mutations in these families.
Single recombination events in the founder haplotypes could not explain the formation of these
haplotypes. However, the great majority of the Finnish disease genes cloned during the 1990s had
one major mutation and typically one, if any additional minor mutations (Ikonen et al. 1991;
Aittomäki et al. 1995; Vesa et al. 1995; Virtaneva et al. 1997).
1.1.3 Linkage disequilibrium studies suggest  the critical region of  300 kb (I)
Linkage disequilibrium (LD) studies were based on testing for the non-random distribution
of alleles at marker loci DXS43, DXS1195, DXS418, DXS9911, DXS999, DXS7161, and DXS365,
the multipoint linkage-disequilibrium analysis, and the Luria-Delbrück method. To fulfill the basic
assumption of LD studies, the segregation of one ancestral mutation in the disease chromosomes,
western and northern patients with highly conserved haplotypes were analyzed separately in these
studies.
Except for DXS9911, the distribution of alleles in western RS chromosomes was
significantly non-random at all loci studied, i.e. linkage disequilibrium was detected with 6 out of 7
markers analyzed. A method based on Luria-Delbrück principle was used for estimating distances
between RS locus and the six markers showing significant linkage disequilibrium. Based on the
distribution of RS carriers’ birthplaces (Vainio-Mattila et al. 1969; Forsius and Eriksson 1980) and
the well characterized population history of Finland (Norio 1981), we estimated that the RS mutation
was introduced into the Finnish population some 40-50 generations ago (corresponding to 20-25
female generations). Assuming a mutation frequency of 10-6, a disease allele frequency of 0.001, and
20 female generations of expansion, the Luria-Delbrück method resulted in an estimated distance of
0.3 cM between RS locus and DXS418. Provided that the average correspondence of 1cM ~1Mb
holds true for the Xp22 region, the estimated genetic distance equals to approximately 300 kb in
physical distance. Finally, consistent with these results, DISMULT analysis (Terwilliger 1995) gave
a Z value of 25.55 < 0.001 cM distal to DXS418. It should be noted, however, that the 99.9%
confidence interval spanned the whole DXS43-DXS365 interval.
In the case of the northern RS patients Pexcess reached the maximum value of 1 for all markers
except for DXS365 (i.e. for the whole 2.1 Mb interval between DXS43 and DXS7161) thus limiting
its usefulness in distance estimations. Data from the northern patients was not used in multipoint
linkage-disequilibrium analysis.
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1.2 Physical mapping of the RS critical  region
1.2.1 YAC contig based restriction mapping (I)
The YAC contig constructed by Alitalo et al. (1995) covers the RS critical region, but
contains some highly unstable YAC clones (such as YAC939H9), as well as clones with known
chimeric character. To avoid problems with chimeric and unstable clones, the region between the
STSs 1774L and 0922R was strengthened by the addition of two new YACs (yWDX6717 and
yWDX3847) from the St. Louis library. One YAC clone from the ICRF library
(CEPHy904E08931) was added to anchor the contig to the proximally flanking marker DXS7161.
As a result of restriction mapping of nine YAC clones spanning the ~1Mb RS candidate interval, we
identified five clusters of CpG nucleotides. In addition, 20 STSs, including five new ones (6717R/L,
3847R/L, and 8931R) were mapped to the interval. Based on restriction mapping and YAC STS
content mapping, the physical distance between the RS flanking markers (DXS418 on the distal side
and DXS7161 on the proximal side) was estimated to be ~850-900 kb.
1.2.2 Construction of a cosmid/PAC contig (unpublished)
Although the 300-kb critical region assigned by the LD analysis was covered by a single
non-chimeric YAC clone (yWXD1774), a cosmid/PAC clone contig was constructed over this most
promising interval to facilitate candidate gene identification. YACs are typically prone to
rearrangements of inserted DNA, and thus they are not the best possible clones to be used in
positional cloning attempts and candidate gene identification techniques. A total of twelve ICRF
cosmid clones positive for YAC 1774, and one PAC obtained with 1774L, were used in the contig
assembly. Altogether 17 new STSs were generated by direct cosmid insert end sequencing (Table 5).
Clone order and orientation were determined by STS content mapping and hybridizations with the
probes DXS418, 1773L, 668R, 1774L, 6717L, 3847L, and DXS9911. Except for a few short
intervals, a bacterial clone coverage of ≥2X between the loci DXS418 and 1774L was obtained
(Figure 7).
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Table 5. New STSs from cosmid insert ends
STS  Primer  sequences (F/R)  B026/T7  5’ GATCTGCCTATCTCGGCCTA 3’
 5’ TGGAGGCTAGAGGTTCTAGAGG 3’
 P228/T7  5’ CGTCCTCCATGAAGTTTAGTCC 3’
 5’ GACTGCCTTTTACATCCAGAGG 3’
 B026/SP6  5’ CATGTGTCAGCAGAGACCTCA 3’
 5’ CCGGATGGTCTATCTCTCCA 3’
 P228/SP6  5’ GAACTGCAGTCATCTCAAGGC 3’
 5’ TGAATCGCTTCTGCCTCC 3’
 A0350/T7  5’ CTTGGAAGGTGAGGTGGAAG 3’
 5’ CTCCTTCGAGACTGGGTCTG 3’
 L0845/T7  5’ GGACTTCACTCCATCCCAGA 3’
 5’ ATCTTGCAGTTGTATGTGTGGC 3’
 A0350/SP6  5’ ATATGTGTGATCTGGGGAAAGG 3’
 5’ AGAGAGGGTCAGTAAGTCCGC 3’
 L0845/SP6  5’ TATCATGAGACATGCAAAAGGG 3’
 5’ AGACATTGGGTTGCCATCTC 3’
 M1254/T7  5’ AGAATCATGGCTCAGAACCC 3’
 5’ CCTGGCACTGTGTATACACA 3’
 E2112/T7  5’ TGGGAAGTGAATGTTTTGCA 3’
 5’ CCCCAGGGTTAAATGACATG 3’
 M1254/SP6  5’ TTAGCCTCACATCCATCAGG 3’
 5’ ATCCCTCTCGTGTGAAACCT 3’
 E2112/SP6  5’ GCATCCAAGAACAGAGCCTT 3’
 5’ ATCCTGATGGTTGATTGTGTTG 3’
 G0453/T7  5’ ATCTCACTGCCAAGTTGTCC 3’
 5’ CCATCAAGAATTTCCTGTGC 3’
 E1527/T7  5’ TCAGAGAATGGTGGCTTGG 3’
 5’ CTTTGAAGGCAAAAAGCAGG 3’
 I0253/T7  5’ AAGTGTGTGCCACCATGC 3’
 5’ TGGAGAGAGGAAATCAAAGGG 3’
 E1527/SP6  5’ TACAGGTGTGGCTGGTGGTA 3’
 5’ TCCCCTCTACTTGTTGCCC 3’
 I0253/SP6  5’ GGATTTTTGACATGGCCCTA 3’
 5’ GTAGGAAAGAAAGGCAGGGG 3’
Figure 7. Cosmid/PAC contig of the RS region. The contig spans 400 kb
between the marker DXS418 and STS 1774L. Microsatellite markers
(bold) and STSs (plain) are located at the top. New STSs obtained by
cosmid insert end sequencing are indicated as circles (SP6) and boxes
(T7). YAC 1774 encompassing the region is shown by the gray bar.  Sizes
of cosmid clones are not drawn to scale.
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1.3 Large scale sequencing and identification of candidate genes (unpublished)
The Retinoschisis Consortium sequenced a 1.3 Mb region at the Sanger Center (Sanger
Center, Cambridge, UK). From the beginning, this sequence was publicly available via world wide
web (www.sanger.ac.uk). Computer based sequence analyses were performed by the six groups
forming the Retinoschisis Consortium. In our exon predictions we concentrated on the PAC
dJ272E8, which is overlapping with the YAC 1774 (for the PAC contig map see
www.sanger.ac.uk/HGP/ChrX/). Our linkage disequilibrium data (I) had suggested that PAC 272
covers the 300-kb RS critical region. We analyzed several GRAIL-predicted exons by SSCP and
direct sequence analysis. However, all changes that were identified proved to be polymorphisms as
they were also found in control individuals. A total of four novel human genes were identified by the
groups of the Retinoschisis Consortium, but all of them were excluded from being the causative gene
for RS (Montini et al. 1997; Montini et al. 1998; van de Vosse et al. 1998; Walpole et al. 1999).
1.4 The extended haplotype analysis and genealogical studies reveal a third founder haplotype
(III, unpublished)
After isolation of DXS9911 and DXS9912, we identified 13 new microsatellite markers by
screening the PAC sequences produced as a result of the large-scale sequencing at the Sanger
Center. Five of these, CA1, CA3, CA6, TAAA, and TAAA2, were shown to have more than three
alleles, and were therefore analyzed in detail. DNA from 100 normal X chromosomes from the
Finnish population were used to determine allele sizes and frequencies for the new markers. A
recombination detected with CA1 in one western family (Figure 8) narrowed the RS critical region
by ~30 kb from the telomeric boundary DXS418 (unpublished).
fam 2fam 16 fam 11fam 22
DXS43
DXS418
CA1
DXS9911
CA6
CA3
DXS7161
DXS999
DXS365
DXS274
DXS41
DXS92
DXS257
Figure 8.  Informative meiosis with crossovers in
the DXS43-DXS92 region. The observed
recombinations restricted the RS gene region
between the markers CA1 and DXS7161. Symbols:
 affected male,  normal male,  allele
segregating with the normal chromosome, 
allele segregating with the RS chromosome,  nd
or not informative
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Extended haplotypes were constructed by the use of the five newly identified markers, which
mapped within the 1 Mb critical interval between DXS418 and DXS7161. Altogether 55
retinoschisis families were genotyped and the new allele data were incorporated into the previous
disease haplotypes. At this point, an interesting observation was made: the basic western haplotype
further divided into two distinct haplotypes with minor differences in alleles of the loci DXS418,
CA3, and TAAA2 (Figure 9). These changes were interpreted as microsatellite marker mutations.
The “major western” haplotype was found in 30 families, whereas the “minor western” haplotype
was present in 10 families. In agreement with the previous haplotype analyses (Alitalo et al. 1991, I),
all the northern patients shared conserved alleles at each of the five new marker loci studied. Ignoring
the minor changes at loci DXS418, CA3, and TAAA2, the two western and the one northern
haplotypes were found in 90% of the families genotyped (50/55 families). In addition, two of the
new families which had been added to the extended haplotype analysis, carried new, distinct
haplotypes with very little homology to other RS haplotypes (Families 39 and 41).
Genealogical studies were first performed in 39 families, who were included in the linkage
and linkage disequilibrium studies (I). Later on, genealogical studies were extended to comprise
altogether 55 RS families (for a map of carrier birthplaces, see III). Based on these studies, the
families were classified into four subgroups: 1) families whose ancestors were born in the south-
western parts of Finland, near the town of Pori (n=30), 2) families originating mainly from a few
neighboring south-western parishes about 50 km from the town of Pori (n=10), 3) families from the
northern parts of Finland (n=10), and 4) individual families from central and southern parts of the
country (n=5). Affected males in subgroups 1, 2, and 3 showed conserved haplotypes over the
DXS418-DXS7161 region.  
The number of clearly distinct haplotypes identified (n=8) as a result of the extended
haplotype analysis, combined with the results of the genealogical studies suggested that eight
different retinoschisis causing mutations might be segregating in the Finnish RS families.
50
DX
S7
16
1
Northern basic
Northern extended
Western basic
Western extended
DX
S7
16
1
DX
S4
18
DX
S9
911
DX
S9
99
CA
1
TA
AACA
6
TA
AA
2
CA
3
12 - 3 - 5 - 1 - 3 - 1 - 3 - 1 - 7
DX
S4
18
DX
S9
911
DX
S9
99
   8  -  6  -  3  -  5
DX
S7
16
1
DX
S4
18
DX
S9
911
DX
S9
99
DX
S7
16
1
CA
1
TA
AA CA
6
TA
AA
2
CA
3
8 - 3 - 6 - 5 - 2 - 3 - 2 - 3 - 5
7  -3 - 6 - 5 - 2 - 3 - 2 - 3 - 5
8 - 3 - 6 - 5 - 2 - 3 - 1 - 3 - 5
7 - 3 - 7 - 3 - 3 - 1 - 4 - 1 - 5
8 - 3 - 7 - 3 - 3 - 1 - 4 - 1 - 5
8 - 3 - 7 - 4 - 3 - 1 - 4 - 1 - 5
Western
major
Western
minor
DX
S4
18
DX
S9
911
DX
S9
99
 12  -  5  -  1  -  7
1.5 Identification of the retinoschisis gene
The gene causing X-linked juvenile retinoschisis, RS1, was finally identified by Sauer and co-
workers in 1997 (see page 20; Sauer et al. 1997). The gene was shown to be located ~200 kb distal
to the marker DXS7161. Identification of this novel gene was achieved by positional cloning
techniques, including exon-trapping, cDNA selection, and direct sequence analysis of the PAC
contig based sequence.
Figure 9.  Haplotypes associated with Finnish founder mutations. The map shows the birthplaces
of 50 females carrying either the western major (area in gray, n=30), western minor (open
circles, n=10), or northern haplotype (black circles, n=10).
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2. Mutation analyses of the RS1 gene (II,III,IV)
2.1 Finnish mutations (III)
Immediately after the RS1 gene was characterized, we started to search for mutations in our
Finnish RS patients by exon specific PCR and SSCP. As a result, we detected seven missense
mutations all located in RS1 exons 4 and 6.
As expected, all patients with the major western haplotype (with the minor changes at loci
DXS418 and TAAA2) carried the same G to A transition at cDNA position 214 (exon 4). This
mutation, termed Western I, accounts for 70% of the RS patients in Finland. RS patients with the
minor western haplotype were shown to carry a G to T transversion at cDNA position 221, which is
only seven bases apart from the Western I mutation. Patients with the northern haplotype had a G to
C change at position 325 (exon 4). The Western II and Northern mutations are responsible for 6%
and 19% of the Finnish patients, respectively. Together these three founder mutations account for
95% of Finnish RS cases. The unrelated families with distinct haplotypes had the mutations
312C>G (exon 4), 554C>A (exon 6), 608C>T (exon 6), and 625C>G (exon 6) (Table 6). The
molecular defect in one sporadic Finnish patient could not be found despite mutation analysis of the
coding sequences and the putative promoter region (Family 41). The mutation in this patient may lie
in other regulatory elements located distantly from the RS1 gene, or in the RS1 intronic regions. We
have also considered the possibility of a wrong diagnosis in the case of this sporadic patient.
However, since the typical cart-wheel like retinal changes can be seen, this seems to be highly
unlikely .
Table 6.  Finnish RS1  mutations
                                                                                                                                                
Mutation at Mutation Mutation at        Haplotype*     Patient
cDNA level      type                  aa level                                                    group                       
214G>A Missense Glu72Lys 8/7-3-6-5-2-3-2/1-3-5     Western I
221G>T Missense Gly74Val 7/8-3-7-3/4-3-1-4-1-5     Western II
312C>G Missense Asn104Lys 7-5-5-4-1-3-3-7-2-1     Private, fam 2
325G>C Missense Gly109Arg 12-3-5-1-3-1-3-1-7-10    Northern
554C>A Missense Thr185Lys 8-3-5-1-3-5-3-7-6-1     Private, fam 39
608C>T Missense Pro203Leu 9-3-6-5-2-3-4-9-2-1     Private, fam 5
625C>G Missense Arg209Gly 8-3-5-3-3-1-3-5-6-1     Private, fam 36
                                                                                                                                                
* Haplotype between the markers DXS418-DXS7161. Whenever two alleles were found at the
same marker loci, the more frequent allele is given first (e.g. 8/7).
Segregation of each mutation in the respective families was confirmed by SSCP or restriction
enzyme based method. To rule out the possibility of polymorphisms, a total of 100 control X-
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chromosomes were analyzed by SSCP. No changes were found in the control individuals and
therefore we concluded that all the changes identified in the RS gene were pathogenic. Besides
analyzing the affected exon, we sequenced the rest of the RS1 exons in some patients of each
conserved haplotype group (Western I, Western II, and Northern) and in all the patients with private
haplotypes. No second alterations were found.
The fact that the main mutation (Western I) accounts for only 70% of the Finnish RS cases
is indeed in contrast to most of the Finnish diseases, which typically show 95-98% prevalence of the
major mutation (Ikonen et al. 1991; Höglund et al. 1996; Virtaneva et al. 1997; Savukoski et al.
1998; Aminoff et al. 1999; Ranta et al. 1999). Nevertheless, some other Finnish diseases, such as
congenital nephrotic syndrome and APECED, show a slightly lower prevalence for the major
mutation (The Finnish-German APECED Consortium, 1997; Kestilä et al. 1998). In these disorders,
the Finmajor mutation has been reported to cause 78% and 82% of the Finnish cases, respectively. The
number of family-specific mutations in the RS1 gene resembles the mutation spectrum of
choroideremia (CHM), another X-linked Finnish disease. According to Sankila et al., one major
founder mutation (CHM*Sal) and three individual mutations account for the choroideremia cases in
Finland (Sankila et al. 1992). Comparisons between retinoschisis and the autosomal dominant
Finnish disease familial amyloidosis (FAF, Maury et al. 1990) do not show much similarities, since
one single molecular defect is causative for all the Finnish FAF cases. The causative gene for the
other dominant Finnish disease, tibilar muscular dystrophy, is not yet known (Haravuori et al. 1998).
2.2 Mutations in foreign RS patients (II)
As a collaborative effort, a thorough mutation analysis of the RS1 gene was performed in
234 familial and sporadic retinoschisis patients of European and North-American origin. The
causative mutation was identified in 91% (214/234) of the cases. A total of 82 different mutations
were identified, 51 of which (62%) occurred only once in the international patient set. The rest of the
mutations identified were typically found in 2 to 10 patients. Contrary to this, the missense mutation
214G>A was carried by 34 apparently unrelated RS patients, thus contributing to 14% of all the
cases studied. As stated earlier, the 214G>A mutation was also found in the great majority (70%) of
the Finnish RS patients (III). Quite recently, two reports from Japan (Hotta et al. 1998; Mashima et
al. 1999) suggested that 214G>A is also responsible for a considerable part of the Japanese RS
cases.
In our patient set two non-Finnish RS patients (Swedish and Danish) were found to carry the
214G>A substitution. The Swedish patient had the conserved Western I haplotype suggesting
emigration from Finland to Sweden, whereas the Danish patient had a totally unique allele
combination. In the Dutch population, the 214G>A mutation occurs in at least three different
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haplotypes. In addition to Finnish, Swedish, Danish, and Dutch patients, we found the 214G>A
mutation in patients of German, British, Italian, and North-American origins. Although haplotype
data from most non-Finnish 214G>A patients are unfortunately not available, it is most likely that
this mutation has several independent origins in different countries and populations.
2.3 Deletion mutations in Danish patients (IV)
Initially, we described exon 1 deletion in four Danish RS patients based on non-successful
PCR amplification (II). Based on genealogical studies, three out of four of the original exon 1
deletion patients were traced into a common superpedigree (RS305). The fourth patient (RS315)
could not be connected to this pedigree, and carried a unique haplotype over the DXS9911-
DXS7161 interval. During the course of the study, we received samples from four additional Danish
patients belonging to the RS305 pedigree.
Deletion characterization was performed by STS mapping, Southern blotting, and “walking”
along uncloned DNA. On the contrary to our initial hypothesis of one intragenic deletion being
responsible for all the eight Danish patients, we actually detected two different deletion mutations in
these patients. First, a 4.4 kb deletion extending from the RS1  5’ UTR to RS1 intron 1 was
identified. This deletion mutation consists of two deleted segments (2.9 and 1.5 kb in size), which
are separated by a 1.2 kb segment of intact DNA. The 4.4-kb two-part deletion was found in all the
patients sharing the common haplotype (pedigree RS305), and it accounts for ~25% of all the
Danish RS cases. The molecular mechanism of this deletion is difficult to predict. Similarly, the role
of the 1.2 kb conserved segment is presently unknown. Ketterling et al. have described a deletion-
insertion-deletion (delindel) rearrangement in the factor IX gene, and suggested that this was caused
by interacting purine-pyrimide loops (Ketterling et al. 1994; 1995). However, this theory cannot be
applied to the 4.4 kb RS1 deletion, due to the absence of purine-pyrimidine repeats in the deletion
junctions.
The second deletion was found in one single Danish family with two affected siblings and
one affected maternal cousin (pedigree RS305). It is a gross deletion abolishing 136 kb of genomic
DNA and causes partial truncation of three genes in the region (PPEF-1, RS1, and STK9, Figure 10).
In addition, as a result of this major rearrangement, the putative promoter regions of PPEF-1 and
RS1 are lost. This deletion is due to Alu-mediated recombination, since both of the deletion
breakpoints were found to be located within repetitive Alu sequences. This deletion is totally unique
in the mutation spectrum of the RS1 gene. Firstly, no other deletions affecting genes adjacent to RS1
have been described so far. Secondly, this is the first retinoschisis causing mutation caused by
repetitive Alu-sequences, which are known to promote recombination and recombination-like events
(Rudiger et al. 1995).
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2.4 Distribution of identified mutations
2.4.1 Single nucleotide substitutions: uneven distribution over the RS1 gene (II,III,
unpublished)
The single nucleotide substitutions show clear clustering in the RS1 discoidin domain
(Figure 11), which extends from amino acid 63 to 219. Moreover, the mutations affecting the
discoidin domain are mostly missense mutations. On the contrary, the single nucleotide changes
characterized in RS1 exons 1, 2, and 3, are mainly translation-truncating nonsense mutations and
splice site mutations. These observations stress the major role of the discoidin domain for correct
function of the retinoschisis protein.
Several nucleotide changes in the DS domain encoding exons hit conserved amino acid
residues. The mutations at evolutionarily conserved amino acids, such as Pro203Leu found in one
Finnish family, are likely to cause dramatic changes in the functional structure of the protein. In
study II, we identified twelve different mutations involving cysteine residues. These mutations affect
both conserved cysteins located within the discoidin region (such as Cys110Tyr and Cys
219Arg/Gly), as well as Cys-residues at less conserved positions. Regardless of the conserved or
Figure 10. The relative locations of RS1, STK-9, and PPEF-1 genes, and the
136 kb deletion identified in two Danish patients. Black bars denote deleted
exons and white bars intact exons. Deleted exons are also numbered. Only part
of the PPEF-1 and STK-9 exons are shown.
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non-conserved nature of the Cys-residues affected, they are of special interest due to their
involvement in disulphide bridge formation, which is one of the basic elements determining the three-
dimensional structure of a protein. Incorrect disulphide bridges are likely to interfere with normal
folding of the RS1 protein and disturb specific interactions with other proteins.
To estimate the missense mutation induced changes in the secondary structure of the RS1
protein, we adopted the Chou&Fasman method (Chou and Fasman 1978) to predict the secondary
structures of wild type and mutant retinoschisin proteins (unpublished). Only the Finnish RS1
mutations were analyzed. The only significant change observed was loss of an α-helix structure
around the site of the Pro203Leu mutation, which replaces a highly conserved proline (Pro203) by a
leucine residue. So far, the three-dimensional structure of a known, “traditional” member of the
discoidin family has not been determined. However, Baumgartner and co-workers recently published
homology-based folding predictions for discoidin containing proteins (Baumgartner et al. 1998).
Based on statistical, structural, and functional evidence they recognized that microbial galactose
oxidase D1 domain (GOase D1) is a distant member of the discoidin family. The 3D structure of
GOase D1 has been determined at 1.7Å resolution (Ito et al. 1994). The crystal structure reveals
eight beta-sheets (b1-b8), whereas the secondary structure prediction shows eight regions of
extended protein structures, most of them overlapping with the beta-sheets. Locations of most of the
conserved amino-acid residues present in the discoidin domain proteins correspond to four of these
beta-sheets (b2, b6, b7, and b8). Furthermore, the three most C-terminal beta-sheets (b6, b7, and b8)
of the RS1 protein contain eight missense mutations. The b3 and b4 structures contain the amino-
acid substitutions Gly135Val, Ile136Thr, and Thr138Ala (in b3), and Glu154X and Tyr155Cys (in
b4). Assuming that the RS1 protein follows the folding prediction by Baumgartner et al. (1998), the
observation that many RS1 missense mutations affect the beta-sheet structures of the DS domain
stress its crucial role for the RS1 protein function, and also give further evidence for the pathogenic
nature of the mutations.
2.4.2 Large intragenic deletions are predominantly found in the 5’ part  of the gene (II, IV)
Intragenic deletions account for approximately 10% of all the retinoschisis causing mutations
identified (Rodriguez et al. 1998; Hiriyanna et al. 1999; Mashima et al. 1999; Shinoda et al. 1999).
In study II, we described intragenic deletions affecting the RS1 exons 1, 2, 3, and 4. In addition,
Mashima et al. (1999) and Hiriyanna et al. (1999) recently described deletions of exon 1 and the
putative promoter region in Japanese and Swedish families. Intragenic deletions seem to have
clustered to the 5’ part, and in particular to the exon 1 region of the retinoschisis gene. Interestingly,
no deletions extending to retinoschisis exons 5-6 have been identified. One reason for this might be
the crucial role of the discoidin domain for the RS1 protein. Any genomic deletion spanning to the
last exons of the RS1 gene would result in a severely deficient DS domain. On the other hand,
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because RS1 and STK9 genes have partly overlapping positions, this kind of deletion would lead to a
more severely truncated serine-threonine kinase encoded by the deleted STK9 gene. Although
genomic deletions have been found in a high proportion of disease genes localized to the short arm
of the X-chromosome (Ballabio and Andria 1992), deletions are considered to be rare in the Xp22.1-
p.22.3 subregion. It has also been hypothesized, that the apparent lack of large deletions in the
Xp22.1-p.22.3 region suggests the presence of one (or more) genes which would lead to lethal
phenotypes when deleted in males (van de Vosse et al. 1998). The 136-kb deletion described by us
is the first gross deletion known to affect both the retinoschisis gene, and genes adjacent to RS1.
Both intragenic deletions identified in the Danish patients are expected to cause transcription
deficient RS1 null alleles. Although the retinoschisis promoter is not yet well characterized, the
immediate 5’ region of the RS1 gene is predicted to contain most of the elements required for
transcription regulation (Gehrig et al. 1999a). Furthermore, the highly restricted expression pattern
of the RS1 gene (Reid et al. 1999; Sauer et al. 1997) is most probably  controlled by regulatory
elements located on the 5’ region of the gene (Kimura et al. 2000).
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2.5 Phenotype-genotype correlation (II,III,IV)
No correlation between the type and site of the disease causing mutations and patients’
phenotypes were observed. Both inter- and intrafamilial phenotypic variations were seen in the case
of all the main Finnish mutations. It is quite surprising that the phenotypes in the Danish 4.4 kb and
360 kb deletion patients were within the normal range, although the amount of functional
Figure 11. Distribution of intragenic deletions (>24 bp, single exon or
multiexonic) and missense mutations over the RS1 gene (each mutation
type was calculated only once). The black bar denotes the discoidin
domain. Source: http://uwcm.web.cf.ac.uk/uwcm/mg/hgmd0.html, Inoue
et al. 2000, IV.
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retinoschisin protein in the retina must be greatly reduced if not totally absent. It is clear that other
factors, such as modifying genes or environmental factors, have an impact on the phenotypic severity
of RS.
3. Secondary sex ratio and gene expression studies (V)
3.1 Secondary sex ratio (V)
Secondary sex ratio (SSR) denotes the proportion of males of total births. Primary sex ratio,
on the other hand, is the male to female ratio at conception. Both of these are biased towards males:
primary sex ratio may be as high as 130/100 (Byrne and Warburton 1987), whereas the average
secondary sex ratio in most Caucasian populations is 106/100  (Jacobsen et al. 1999).
In the 1960s, professor Eriksson and colleagues noticed that carriers of X-linked
retinoschisis from south-western Finland tended to have more sons than daughters, i.e. they had an
exceptionally high SSR in their offspring (Eriksson et al. 1967). Affected males and their healthy
brothers had normal secondary sex ratios. In these SSR studies the carrier status was only based on
pedigree information. Females with either affected father or affected son(s) were considered as
carriers. This classification method leaves out RS carriers who have inherited the defective gene from
their mothers, as well as carriers whose affected sons are too young to manifest any symptoms at the
time of investigation. Moreover, to avoid strong biases in the calculations, one male propositus had to
be omitted from each offspring. This may have led to considerably loss of information in the
calculations.
To be able to confirm or contradict the previous observations, we calculated the SSR in the
offspring of Western I carriers. In these studies we utilized the restriction enzyme based mutation
detection method (III), and a newly introduced statistical formula (Fellman et al. 1999, for a short
description see V). Altogether 202 females belonging to the Western I pedigrees were included in
the study; 149 of them were found to be carriers of the Western I mutation. The statistical analysis
of the carriers resulted in a SSR value of 129.8 (z=2.25), which is remarkably higher than the
standard value  of 106 (Official statistics of Finland 1997). We also noted that SSR in the offspring
of non-carrier females analyzed in our study was slightly higher (SSR 116.7) than the standard value
would suggest. However, this change  is not statistically significant (z=0.51). Furthermore, the
family sizes of Western I carriers were similar to those of average Finns, and we thus concluded that
the defective RS1 gene does not affect carriers’ fertility. High SSR associated with X-linked
retinoschisis has also been reported in non-Finnish sibships by Deutman (1971) and Schepens
(1966).
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The largest natural variation in human SSR is found between different ethnic groups: Asian
populations tend to have the highest secondary sex ratios, whereas the lowest figures are found in the
black populations (James 1985; Ruder 1985). SSR variations within populations are generally
smaller in magnitude. Natural variations have been studied as a function of different biological and
genetic factors, such as hormonal effects, antigen sharing at the HLA region, sex-linked lethal
mutations, parental age, and birth order (Ruder 1985; Astolfi et al. 1996; James 1996; Astolfi and
Zonta 1999). The effect of several environmental factors (socio-economic conditions, pollution,
exposure to heavy metals or chemicals) on SSR has also been intensively studied (Lyster 1981;
Rogan et al. 1999).
Whatever the actual determinant leading to the deviation from the expected SSR value is, it
may act already at conception by influencing the viability of X- and Y-bearing spermatozoa.
According to Graffelman et al. (1999), the percentage of Y-chromosome bearing spermatozoa
(“sperm sex ratio”, 50.3%) cannot alone explain the observed SSR biases at birth. After conception
the SSR may be influenced by changes in the intrauterine conditions. Favourable or unfavourable
intrauterine conditions may alter the SSR by diminishing or increasing the frequency of early sex-
selective abortions. The developmental asynchrony  hypothesis (Pope 1988; Krackow 1995)
explains the altered SSR in mammals by differences in the developmental rates of XX and XY
blastocysts, and the responsiveness of the maternal reproductive organs (Mittwoch 1993). The uterus
responds to implantation signals only during a specific part of the oestrus cycle; outside this time the
intrauterine conditions towards the embryonic survival are hostile. Following Krackow’s asynchrony
hypothesis, uterine responsiveness synchronized with male blastocysts should lead to male bias, and
vice versa.
3.2 RS1 expression in the pregnancy related tissues (V)
In order to test the hypothesis that the defective RS1 protein might cause changes in the
intrauterine conditions, we analyzed the expression of the gene in tissues with important roles during
pregnancy. The expression of RS1 has been shown to be limited to the retinal photoreceptor cells
(Sauer et al. 1997; Reid et al. 1999). By the use of the sensitive RT-PCR analysis, we were able to
show the presence of RS1 gene transcript in the uterus, but not in other pregnancy-related cell types
tested (cytotrophoblasts, decidual cells, full term placenta). Negative RT-PCR results with RS1
specific primers were also obtained with lymphoblast- and fibroblast-derived cDNA. However, since
Northern blot hybridizations with RS1 cDNA failed to give signals from any other tissues than the
eye (unpublished observations) we conclude that RS1 transcript levels in the uterus are very low.
The actual reasons for skewed secondary sex ratio remain to be unsolved. The most
fascinating explanation - a change in the intrauterine conditions caused by the defective RS1 gene - is
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interesting but difficult to prove experimentally. One might hypothesize that the implantation of the
early embryo is somehow controlled by the discoidin domain, which is known to have a role in cell-
to-cell interactions, and that the 214G>A mutation present in the discoidin domain region would
disturb the sensitive controlling mechanisms. During mammalian fertilization and early
embryogenesis, the early embryo is surrounded by zona-pellucida, an extracellular matrix. The one-
cell zygote remains surrounded by this matrix during oviductal transport until the blastocyst stage
(Rankin et al. 1999). Individual zona-proteins and combinations of several zona-associated proteins
are known to control the specificity of sperm-egg interactions (Verhage et al. 1997; Rankin et al.
1999). Milk fat globule, a member of the discoidin domain family, was recently shown to have
structural similarity with a porcine zona-pellucida binding protein P47 (Ensslin et al. 1998). P47 is
expressed in a number of porcine tissues, including the uterus. The structural homology between a
member of the discoidin family and a zona-pellucida binding protein gives room for the speculations
on possible disturbances of the zona-uterus interactions caused by the mutated discoidin domain.
However, it is clear that further studies are needed before the hypothetical intrauterine changes
leading to skewed SSR will be completely understood.
3.3 X-inactivation analysis of RS carriers (V)
We also studied the overall X-inactivation pattern in 48 retinoschisis carriers and their non-
carrier sisters. The X-inactivation status in white blood cells was determined by methylation analysis
of the highly polymorphic trinucleotide repeat in the AR locus (Allen et al. 1992). In the carrier
females, 1 out of 44 females analyzed (2%) had an extremely skewed X-inactivation pattern in her
blood cells. In the group of non-carriers, an extremely skewed (ratio ≥ 90:10) inactivation pattern
was found in two females (2/23; 9%). A skewed pattern (ratio 80:20 - < 90:10), was found in 11% of
the carriers, and in 17% of the non-carriers. The corresponding numbers for moderately skewed
patterns (ratio 70:30- < 80:20) were 30%  and 13%, for the carriers and the non-carriers.
The majority of non-carriers (61%) and carriers (57%) had completely random (ratio 50:50 -
< 70:30) X-inactivation patterns. Therefore, we concluded that the lack of ophthalmoscopic
symptoms in female carriers is not associated to skewed X-inactivation and that the observed low
frequency of skewing can be explained by the normally occurring non-random X-inactivation in
females. It should be noted, however, that the results shown in the present study represent only
inactivation ratios in white blood cells. Inactivation ratios are known to vary among different tissues
of a given individual (Busque et al. 1996; Gale et al. 1994). In addition, Tan et al. (1993) have
demonstrated that the whole X-inactivation process proceeds with different schedules in different
tissues, and thus X-inactivation is strictly a tissue-specific phenomenon.
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CONCLUSIONS AND FUTURE PROSPECTS
This thesis describes the molecular genetic studies of X-linked juvenile retinoschisis. The
main results can be briefly summarized as follows:
Linkage studies and recombination mapping with new polymorphic markers allowed us to
localize the RS gene between the markers CA1 and DXS7161. In order to characterize this
subgenomic region in more detail, both YAC and cosmid/PAC clone contigs covering the critical RS
region were constructed. Restriction mapping revealed the presence of five putative CpG islands
within the 900 kb region. After identification of the gene causative for retinoschisis, we focused on
characterization of the molecular defects in the RS1 gene. Three distinct founder mutations (Western
I, Western II, and Northern) were found to be responsible for approximately 95% of all RS patients
in Finland. In addition, we identified four family-specific mutations segregating in the Finnish RS
families. Altogether 82 different disease causing mutations were detected in an extensive mutation
analysis of 234 familial and sporadic retinoschisis patients of European and North-American origin.
Most of the RS causing mutations, predominantly missense mutations, were found in the RS1 exons
4, 5, and 6, emphasizing the functional importance of the carboxy-terminal part of the protein. We
also identified two unique deletion mutations causing retinoschisis in Danish families. Both of these
mutations were found to delete the putative promoter region of the RS1 gene, therefore leading to
transcription deficient null-alleles. The larger deletion also abolishes exons of two other genes
(PPEF1 and STK9), which were found to be located in close vicinity of the retinoschisis gene.
Interestingly, the Danish patients have a typical retinoschisis phenotype, even though they most
probably lack the RS1 gene product.
We also determined the secondary sex ratio (SSR) in the offspring of carriers of the
Western I mutation, and the overall X-inactivation status of these carriers. We were able to
demonstrate that in the offspring of Western I carriers the SSR is significantly higher than the
standard value in the Finnish population. The overall X-inactivation pattern in the white blood cells of
the carriers was normal. To be able to elucidate the reasons leading to skewed secondary sex ratio in
the retinoschisis families, the RS1 expression pattern in several pregnancy related tissues was
analyzed. We were able to show that RS1 transcripts are present in the human uterus. Therefore, we
hypothesized that the RS protein has a role in implantation or early embryonic survival.
In addition to the RS1 gene defects reported by us, a number of other papers describing
mutations of European, North- and South-American, and Asian retinoschisis patients have been
published (Hotta et al. 1998; Rodriguez et al. 1998; Hiriyanna et al. 1999; Mendoza-Londono et al.
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1999; Shastry et al. 1999; Shinoda et al. 1999; Sieving et al. 1999; Hiraoka et al. 2000; Inoue et al.
2000). Based on the RS1 mutation spectrum it can be concluded that 1) retinoschisis is worldwidely
more common condition than previously thought, and that 2) the RS1 gene has a high new mutation
rate. Furthermore, based on the haplotype data from patients carrying the same mutation it can be
concluded that the disease has several independent origins. Detailed, regularly updated retinoschisis
mutation data are available at RetinoschisisDB© (http://www.dmd.nl/rs/rshome.html) and at The
Human Gene Mutation Database (http://uwcm.web.cf.ac.uk/uwcm/mg/hgmd0.html)
The identification of the main Finnish RS1 mutations led immediately to diagnostic
applications. Patients with atypical clinical manifestation can be easily verified by simple DNA tests.
It is also possible to offer pre- and postnatal, as well as carrier diagnosis to retinoschisis families
from the high risk areas (such as the southwestern regions of Finland). At present there is no cure
for the degenerative process of juvenile retinoschisis. Therefore, early and accurate diagnosis is
important in genetic counselling of RS families. Early diagnosis enables the utilization of special
requirements for the educational needs for a child with a mild to severe visual handicap.
At present, the severity of retinoschisis phenotype cannot be predicted on the basis of the
mutation identified. Retinoschisis patients carrying the same nucleotide substitution typically show
the whole range of mild to severe clinical phenotypes. It is not yet clear why, and how a single
nucleotide change in a single gene produces such variable clinical phenotypes. The determinants
involved in the final refinement of the phenotype include gene interactions between RS1 and other
genes (e.g. modifier loci), interactions of the mutated RS1 gene product with other proteins, and the
influence of the external environment. It is clear that more information about modifier loci needs to
be generated before the question about RS phenotype variability can be answered.
Based on the features found on the predicted protein, the retinoschisin is suggested to play a
role in cell-to-cell interactions on membrane surfaces. According to immunohistochemistry studies
(Trump et al. 1999) the RS1 gene product has been classified to be a secreted photoreceptor protein.
Future studies will be focused on the identification of the retinoschisin action sites, and, perhaps
more importantly, on the characterization of the retinal proteins interacting with the RS1 gene
product, possibly via its discoidin domain. It would be interesting to see whether the long lasting
hypothesis of the involvement of the Müller cells in the pathogenesis of retinoschisis can be verified
experimentally. Another important area of future retinoschisis studies is the tissue-specific and
temporal regulation of RS1 expression. Data of the expression during embryonic development will
also be highly relevant with regard to another momentous question: at which stage does the damage
in nervous retina become irreversible? Generation of a RS mouse model by gene targeting approach
would be a valuable tool for addressing these questions.
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